ROCK1
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| O00429 | S637 | SIGNOR | DNM1L DLP1 DRP1 | PQKGHAVNLLDVPVPVARKLsAREQRDCEVIERLIKSYFLI |
| O14617 | S658 | Sugiyama | AP3D1 PRO0039 | DERPRAVFHEEEQRRPKHRPsEADEEELARRREARKQEQAN |
| O14649 | S336 | SIGNOR|PSP | KCNK3 TASK TASK1 | KSREKLQySIPMIIPRDLSTsDTCVEQSHSSPGGGGRYSDT |
| O14649 | S393 | SIGNOR|PSP | KCNK3 TASK TASK1 | sVsTGLHSLStFRGLMKRRssV___________________ |
| O14744 | T80 | EPSD|PSP | PRMT5 HRMT1L5 IBP72 JBP1 SKB1 | KNRPGPQTRSDLLLSGRDWNtLIVGKLSPWIRPDSKVEKIR |
| O14950 | S20 | SIGNOR|EPSD|PSP|Sugiyama | MYL12B MRLC2 MYLC2B | _MSSKKAKTKTTKKRPQRAtsNVFAMFDQSQIQEFKEAFNM |
| O14950 | T19 | SIGNOR|EPSD|PSP|Sugiyama | MYL12B MRLC2 MYLC2B | __MSSKKAKTKTTKKRPQRAtsNVFAMFDQSQIQEFKEAFN |
| O14974 | S692 | Sugiyama | PPP1R12A MBS MYPT1 | PVRDEEsEsQRKARSRQARQsRRstQGVtLtDLQEAEKtIG |
| O14974 | S852 | EPSD|PSP | PPP1R12A MBS MYPT1 | EDKSQPKSIRERRRPREKRRstGVSFWtQDsDENEQEQQsD |
| O14974 | S903 | Sugiyama | PPP1R12A MBS MYPT1 | QtDsIsRyETssTsAGDRyDsLLGRsGsysYLEERKPYSSR |
| O14974 | T696 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP|Sugiyama | PPP1R12A MBS MYPT1 | EEsEsQRKARSRQARQsRRstQGVtLtDLQEAEKtIGRSRS |
| O14974 | T700 | Sugiyama | PPP1R12A MBS MYPT1 | sQRKARSRQARQsRRstQGVtLtDLQEAEKtIGRSRSTRTR |
| O14974 | T853 | SIGNOR|iPTMNet|EPSD|PSP | PPP1R12A MBS MYPT1 | DKSQPKSIRERRRPREKRRstGVSFWtQDsDENEQEQQsDt |
| O14980 | S1055 | Sugiyama | XPO1 CRM1 | LEEREIALRQADEEKHKRQMsVPGIFNPHEIPEEMCD____ |
| O43175 | T78 | Sugiyama | PHGDH PGDH3 | KVTADVINAAEKLQVVGRAGtGVDNVDLEAAtRKGILVMNT |
| O43293 | T265 | GPS6|EPSD|PSP | DAPK3 ZIPK | SELAKDFIRRLLVKDPKRRMtIAQSLEHSWIKAIRRRNVRG |
| O43293 | T299 | GPS6|EPSD|PSP | DAPK3 ZIPK | RRRNVRGEDSGRKPERRRLKtTRLKEYtIKsHssLPPNNsY |
| O43318 | S439 | Sugiyama | MAP3K7 TAK1 | GNILDVPEIVISGNGQPRRRsIQDLtVtGTEPGQVssRsss |
| O60237 | T646 | SIGNOR|EPSD|PSP | PPP1R12B MYPT2 | EEAESLRKARSRQARQTRRstQGVTLTDLQEAERTFSRSRA |
| O60739 | T45 | Sugiyama | EIF1B | AGTEDyIHIRIQQRNGRKtLttVQGIADDyDKKKLVKAFKK |
| O60814 | S37 | Sugiyama | H2BC12 H2BFT HIRIP1 HIST1H2BK | KAVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| O60814 | S39 | Sugiyama | H2BC12 H2BFT HIRIP1 HIST1H2BK | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| O60841 | S107 | Sugiyama | EIF5B IF2 KIAA0741 | NEEEFtsKDKKKKGQKGKKQsFDDNDsEELEDKDsKSKKTA |
| O60841 | T78 | Sugiyama | EIF5B IF2 KIAA0741 | ILKELEELsLEAQGIKADREtVAVKPTENNEEEFtsKDKKK |
| O75116 | S134 | Sugiyama | ROCK2 KIAA0619 | SQKVYAMKLLSKFEMIKRSDsAFFWEERDIMAFANSPWVVQ |
| O75116 | T235 | Sugiyama | ROCK2 KIAA0619 | VKPDNMLLDKHGHLKLADFGtCMKMDETGMVHCDtAVGTPD |
| O75534 | T761 | Sugiyama | CSDE1 D1S155E KIAA0885 NRU UNR | GPKAVAAPRPDRLVNRLKNItLDDAsAPRLMVLRQPRGPDN |
| O75665 | S899 | Sugiyama | OFD1 CXorf5 | EEKIREQQVKERRQREERRQsNLQEVLERERRELEKLyQER |
| O95425 | T852 | Sugiyama | SVIL | AISTRNRIDTRQRRMNARyQtQPVTLGEVEQVQSGKLIPFS |
| P00338 | T322 | Sugiyama | LDHA PIG19 | DLVKVTLtsEEEARLKKsADtLWGIQKELQF__________ |
| P02545 | S282 | Sugiyama | LMNA LMN1 | ELEKTYSAKLDNARQsAERNsNLVGAAHEELQQsRIRIDsL |
| P04075 | S46 | Sugiyama | ALDOA ALDA | PGKGILAADEstGsIAKRLQsIGtENtEENRRFyRQLLLtA |
| P04075 | T37 | Sugiyama | ALDOA ALDA | sDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRR |
| P04150 | S617 | PSP | NR3C1 GRL | QYSWMFLMAFALGWRSYRQSsANLLCFAPDLIINEQRMtLP |
| P04150 | T519 | PSP | NR3C1 GRL | GIQQATTGVsQETSENPGNKtIVPAtLPQLTPTLVSLLEVI |
| P04406 | S241 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | IPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKV |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P05455 | S94 | Sugiyama | SSB | KSKAELMEIsEDKTKIRRsPsKPLPEVTDEyKNDVKNRsVY |
| P06733 | T205 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | GAEVyHNLKNVIKEKyGKDAtNVGDEGGFAPNILENKEGLE |
| P06737 | S430 | Sugiyama | PYGL | KHLDRIVALFPKDVDRLRRMsLIEEEGSKRINMAHLCIVGS |
| P06744 | S107 | Sugiyama | GPI | GEKINyTEGRAVLHVALRNRsNtPILVDGKDVMPEVNKVLD |
| P06744 | T109 | Sugiyama | GPI | KINyTEGRAVLHVALRNRsNtPILVDGKDVMPEVNKVLDKM |
| P06899 | S39 | Sugiyama | H2BC11 H2BFR HIST1H2BJ | VTKAQKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGISSKA |
| P07195 | T302 | Sugiyama | LDHB | YGIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsAD |
| P07737 | S138 | GPS6|SIGNOR|EPSD|PSP | PFN1 | GVHGGLINKKCyEMAsHLRRsQY__________________ |
| P07900 | S63 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | IFLRELIsNssDALDKIRyEsLtDPsKLDsGKELHINLIPN |
| P08238 | S452 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | AFSKNLKLGIHEDstNRRRLsELLRyHtsQsGDEMtsLsEy |
| P08238 | S462 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | HEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKs |
| P08238 | S58 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | IFLRELIsNAsDALDKIRyEsLtDPsKLDsGKELKIDIIPN |
| P08238 | T85 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | LDsGKELKIDIIPNPQERtLtLVDtGIGMtKADLINNLGtI |
| P08238 | T89 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | KELKIDIIPNPQERtLtLVDtGIGMtKADLINNLGtIAKSG |
| P08670 | S72 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | VIM | LyAssPGGVyAtRssAVRLRssVPGVRLLQDsVDFsLADAI |
| P08670 | T327 | Sugiyama | VIM | DALRQAKQESTEYRRQVQsLtCEVDALKGtNEsLERQMREM |
| P08758 | T8 | Sugiyama | ANXA5 ANX5 ENX2 PP4 | _____________MAQVLRGtVtDFPGFDERADAEtLRKAM |
| P09382 | T58 | Sugiyama | LGALS1 | DsNNLCLHFNPRFNAHGDANtIVCNsKDGGAWGTEQREAVF |
| P10412 | S36 | Sugiyama | H1-4 H1F4 HIST1H1E | EKtPVKKKARKsAGAAKRKAsGPPVsELItKAVAASKERsG |
| P10412 | S55 | Sugiyama | H1-4 H1F4 HIST1H1E | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P10412 | S58 | Sugiyama | H1-4 H1F4 HIST1H1E | PPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEKNNS |
| P11142 | S40 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P11142 | T163 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VVtVPAyFNDsQRQAtKDAGtIAGLNVLRIINEPtAAAIAy |
| P11142 | T226 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | DVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVNHFIAEFK |
| P11142 | T64 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | FtDtERLIGDAAKNQVAMNPtNtVFDAKRLIGRRFDDAVVQ |
| P11441 | S128 | Sugiyama | UBL4A DXS254E GDX UBL4 | SAADASRVLEQLQRDYERSLsRLTLDDIERLASRFLHPEVT |
| P11940 | T191 | Sugiyama | PABPC1 PAB1 PABP PABP1 PABPC2 | GRFKSRKEREAELGARAKEFtNVyIKNFGEDMDDERLKDLF |
| P13489 | T176 | Sugiyama | RNH1 PRI RNH | AASCEPLASVLRAKPDFKELtVsNNDINEAGVRVLCQGLKD |
| P13639 | S23 | Sugiyama | EEF2 EF2 | NFtVDQIRAIMDKKANIRNMsVIAHVDHGKStLtDsLVCKA |
| P13639 | T5 | Sugiyama | EEF2 EF2 | ________________MVNFtVDQIRAIMDKKANIRNMsVI |
| P13861 | S99 | Sugiyama | PRKAR2A PKR2 PRKAR2 | EsEEDEDLEVPVPsRFNRRVsVCAEtyNPDEEEEDTDPRVI |
| P14136 | S13 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | GFAP | ________MERRRItsAARRsYVssGEMMVGGLAPGRRLGP |
| P14136 | S17 | iPTMNet|EPSD | GFAP | ____MERRRItsAARRsYVssGEMMVGGLAPGRRLGPGTRL |
| P14136 | S38 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | GFAP | GEMMVGGLAPGRRLGPGTRLsLARMPPPLPTRVDFSLAGAL |
| P14136 | T7 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | GFAP | ______________MERRRItsAARRsYVssGEMMVGGLAP |
| P14314 | S126 | Sugiyama | PRKCSH G19P1 | yNsGVICENtCKEKGRKEREsLQQMAEVtREGFRLKKILIE |
| P14314 | T469 | Sugiyama | PRKCSH G19P1 | WGsWIGPDHDKFSAMKyEQGtGCWQGPNRstTVRLLCGKEt |
| P14618 | T45 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | TFLEHMCRLDIDsPPItARNtGIICtIGPAsRsVEtLKEMI |
| P15311 | T533 | Sugiyama | EZR VIL2 | NEEKRITEAEKNERVQRQLLtLssELsQARDENKRTHNDII |
| P15311 | T567 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | EZR VIL2 | RTHNDIIHNENMRQGRDKYKtLRQIRQGNTKQRIDEFEAL_ |
| P15880 | T202 | Sugiyama | RPS2 RPS4 | CKVTGRCGsVLVRLIPAPRGtGIVsAPVPKKLLMMAGIDDC |
| P15880 | T230 | Sugiyama | RPS2 RPS4 | PKKLLMMAGIDDCytsARGCtAtLGNFAKATFDAISKTysy |
| P16402 | S37 | Sugiyama | H1-3 H1F3 HIST1H1D | KtPVKKKAKKAGATAGKRKAsGPPVsELItKAVAASKERsG |
| P16402 | S56 | Sugiyama | H1-3 H1F3 HIST1H1D | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P16402 | S59 | Sugiyama | H1-3 H1F3 HIST1H1D | PPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEKNNS |
| P16403 | S55 | Sugiyama | H1-2 H1F2 HIST1H1C | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P16403 | S58 | Sugiyama | H1-2 H1F2 HIST1H1C | PPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEKNNS |
| P17066 | S42 | Sugiyama | HSPA6 HSP70B' | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P17066 | T228 | Sugiyama | HSPA6 HSP70B' | DVSVLSIDAGVFEVKAtAGDtHLGGEDFDNRLVNHFMEEFR |
| P17661 | S12 | EPSD|PSP | DES | _________MSQAYSSsQRVssYRRtFGGAPGFPLGsPLss |
| P17661 | S60 | EPSD|PSP | DES | FGsKGssssVTSRVYQVSRtsGGAGGLGsLRAsRLGttRtP |
| P17661 | T17 | SIGNOR|ELM|iPTMNet|EPSD|PSP | DES | ____MSQAYSSsQRVssYRRtFGGAPGFPLGsPLssPVFPR |
| P17661 | T76 | SIGNOR|ELM|iPTMNet|EPSD|PSP | DES | VSRtsGGAGGLGsLRAsRLGttRtPssyGAGELLDFsLADA |
| P17661 | T77 | SIGNOR|ELM|iPTMNet|EPSD|PSP | DES | SRtsGGAGGLGsLRAsRLGttRtPssyGAGELLDFsLADAV |
| P18621 | S5 | Sugiyama | RPL17 | ________________MVRysLDPENPtKsCKSRGSNLRVH |
| P18859 | S57 | Sugiyama | ATP5PF ATP5A ATP5J ATPM | DPIQKLFVDKIREYKSKRQTsGGPVDAssEyQQELERELFK |
| P19105 | S19 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|Sugiyama | MYL12A MLCB MRLC3 RLC | __MSSKRTKTKTKKRPQRAtsNVFAMFDQSQIQEFKEAFNM |
| P19105 | T18 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|Sugiyama | MYL12A MLCB MRLC3 RLC | ___MSSKRTKTKTKKRPQRAtsNVFAMFDQSQIQEFKEAFN |
| P19338 | S460 | Sugiyama | NCL | ADAEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNST |
| P19634 | T653 | EPSD|PSP | SLC9A1 APNH1 NHE1 | KILRNNLQKTRQRLRsyNRHtLVADPyEEAWNQMLLRRQKA |
| P23396 | T70 | Sugiyama | RPS3 OK/SW-cl.26 | ILATRTQNVLGEKGRRIRELtAVVQKRFGFPEGsVELyAEK |
| P23527 | S39 | Sugiyama | H2BC17 H2BFH H2BFN HIST1H2BO | VTKAQKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGISSKA |
| P23588 | S122 | Sugiyama | EIF4B | NLPyDVTEESIKEFFRGLNIsAVRLPREPsNPERLKGFGyA |
| P23588 | T205 | Sugiyama | EIF4B | GRDRNRDsDKtDTDWRARPAtDsFDDyPPRRGDDsFGDKYR |
| P24844 | S20 | GPS6|SIGNOR|EPSD|PSP|Sugiyama | MYL9 MLC2 MRLC1 MYRL2 | _MssKRAKAKtTKKRPQRAtsNVFAMFDQSQIQEFKEAFNM |
| P24844 | T19 | SIGNOR|EPSD|PSP|Sugiyama | MYL9 MLC2 MRLC1 MYRL2 | __MssKRAKAKtTKKRPQRAtsNVFAMFDQSQIQEFKEAFN |
| P26038 | T526 | Sugiyama | MSN | EERTTEAEKNERVQKHLKALtsELANARDEsKKTANDMIHA |
| P26038 | T558 | SIGNOR|ELM|iPTMNet|EPSD|PSP | MSN | KTANDMIHAENMRLGRDKYKtLRQIRQGNTKQRIDEFEsM_ |
| P26373 | S181 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | YKKEKARVItEEEKNFKAFAsLRMARANARLFGIRAKRAKE |
| P26373 | S77 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PIVRCPTVRYHTKVRAGRGFsLEELRVAGIHKKVARTIGIs |
| P26373 | T148 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PRKPSAPKKGDssAEELKLAtQLtGPVMPVRNVYKKEKARV |
| P26373 | T151 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PSAPKKGDssAEELKLAtQLtGPVMPVRNVYKKEKARVItE |
| P26373 | T24 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | SRNGMVLKPHFHKDWQRRVAtWFNQPARKIRRRKARQAKAR |
| P27348 | S45 | Sugiyama | YWHAQ | CMKAVtEQGAELsNEERNLLsVAyKNVVGGRRSAWRVIsSI |
| P27708 | S1859 | Sugiyama | CAD | RGIPGLPDGRFHLPPRIHRAsDPGLPAEEPKEKSSRKVAEP |
| P29474 | T495 | PSP | NOS3 | YQPDPWKGSAAKGTGITRKKtFKEVANAVKISASLMGTVMA |
| P29966 | S159 | EPSD|PSP | MARCKS MACS PRKCSL | EDGAtPsPsNEtPKKKKKRFsFKKsFKLsGFsFKKNKKEAG |
| P30086 | S52 | Sugiyama | PEBP1 PBP PEBP | AAVDELGKVLtPtQVKNRPtsIsWDGLDsGKLytLVLtDPD |
| P30086 | S54 | Sugiyama | PEBP1 PBP PEBP | VDELGKVLtPtQVKNRPtsIsWDGLDsGKLytLVLtDPDAP |
| P31946 | S47 | Sugiyama | YWHAB | AMKAVtEQGHELsNEERNLLsVAyKNVVGARRSsWRVIsSI |
| P31947 | S45 | Sugiyama | SFN HME1 | FMKGAVEKGEELsCEERNLLsVAyKNVVGGQRAAWRVLSsI |
| P32119 | T142 | Sugiyama | PRDX2 NKEFB TDPX1 | EGIAYRGLFIIDGKGVLRQItVNDLPVGRsVDEALRLVQAF |
| P33778 | S39 | Sugiyama | H2BC3 H2BFF HIST1H2BB | ITKAQKKDGKKRKRsRKEsysIyVyKVLKQVHPDTGISSKA |
| P34931 | S42 | Sugiyama | HSPA1L | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P34931 | T228 | Sugiyama | HSPA1L | DVSILTIDDGIFEVKAtAGDtHLGGEDFDNRLVsHFVEEFK |
| P34932 | S76 | Sugiyama | HSPA4 APG2 HSPH2 | VISNAKNTVQGFKRFHGRAFsDPFVEAEKSNLAYDIVQLPT |
| P35241 | T564 | SIGNOR|ELM|iPTMNet|EPSD|PSP | RDX | KTQNDVLHAENVKAGRDKYKtLRQIRQGNtKQRIDEFEAM_ |
| P35241 | T573 | SIGNOR|ELM|iPTMNet|EPSD | RDX | ENVKAGRDKYKtLRQIRQGNtKQRIDEFEAM__________ |
| P35269 | T156 | Sugiyama | GTF2F1 RAP74 | EAFPVHNWYNFTPLARHRtLtAEEAEEEWERRNKVLNHFSI |
| P35611 | T445 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | ADD1 ADDA | GDsGtCsPLRHsFQKQQREKtRWLNSGRGDEASEEGQNGss |
| P35611 | T480 | SIGNOR|ELM|EPSD|PSP | ADD1 ADDA | GQNGssPKsKTKWTKEDGHRtstsAVPNLFVPLNTNPKEVQ |
| P37108 | T45 | Sugiyama | SRP14 | sVyItLKKYDGRTKPIPKKGtVEGFEPADNKCLLRATDGKK |
| P37802 | S163 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | LFsGDPNWFPKKSKENPRNFsDNQLQEGKNVIGLQMGtNRG |
| P37802 | T180 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | RNFsDNQLQEGKNVIGLQMGtNRGAsQAGMtGyGMPRQIL_ |
| P37837 | S13 | Sugiyama | TALDO1 TAL TALDO TALDOR | ________MsssPVKRQRMEsALDQLKQFTTVVADTGDFHA |
| P38646 | S89 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | VMEGKQAKVLENAEGARttPsVVAFtADGERLVGMPAKRQA |
| P38646 | T94 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | QAKVLENAEGARttPsVVAFtADGERLVGMPAKRQAVtNPN |
| P39019 | Y54 | Sugiyama | RPS19 | VDtVKLAKHKELAPyDENWFytRAAstARHLYLRGGAGVGs |
| P39023 | S13 | Sugiyama | RPL3 OK/SW-cl.32 | ________MSHRKFSAPRHGsLGFLPRKRSSRHRGKVKSFP |
| P41181 | T269 | PSP | AQP2 | REVRRRQsVELHsPQsLPRGtKA__________________ |
| P41567 | T45 | Sugiyama | EIF1 SUI1 | AGTEDyIHIRIQQRNGRKtLttVQGIADDyDKKKLVKAFKK |
| P42677 | T74 | Sugiyama | RPS27 MPS1 | VLCVGCSTVLCQPTGGKARLtEGCsFRRKQH__________ |
| P43243 | T150 | Sugiyama | MATR3 KIAA0723 | EDKItPENLPQILLQLKRRRtEEGPtLsyGRDGRsAtREPP |
| P46013 | S648 | Sugiyama | MKI67 | RVSISRsQHDILQMICSKRRsGAsEANLIVAKSWADVVKLG |
| P46776 | S68 | Sugiyama | RPL27A | yHPGyFGKVGMKHYHLKRNQsFCPtVNLDKLWtLVsEQtRV |
| P46777 | S224 | Sugiyama | RPL5 MSTP030 | VADyMRyLMEEDEDAyKKQFsQyIKNsVtPDMMEEMyKKAH |
| P46778 | T124 | Sugiyama | RPL21 | sFLKRVKENDQKKKEAKEKGtWVQLKRQPAPPREAHFVRTN |
| P48436 | S181 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | SOX9 | LRVQHKKDHPDYKYQPRRRKsVKNGQAEAEEATEQtHIsPN |
| P48741 | S42 | Sugiyama | HSPA7 HSP70B | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P48741 | T228 | Sugiyama | HSPA7 HSP70B | DVSVLSIDAGVFEVKAtAGDtHLGGEDFDNRLVNHFMEEFR |
| P49327 | T2215 | Sugiyama | FASN FAS | DEAsELACPtPKEDGLAQQQtQLNLRSLLVNPEGPtLMRLN |
| P50552 | S157 | GPS6|EPSD | VASP | EVEQQKRQQPGPSEHIERRVsNAGGPPAPPAGGPPPPPGPP |
| P50991 | S51 | Sugiyama | CCT4 CCTD SRB | AQIRFsNISAAKAVADAIRtsLGPKGMDKMIQDGKGDVtIt |
| P50991 | T50 | Sugiyama | CCT4 CCTD SRB | PAQIRFsNISAAKAVADAIRtsLGPKGMDKMIQDGKGDVtI |
| P51116 | S504 | Sugiyama | FXR2 FMR1L2 | PTGGRGRGPPPAPRPTSRYNsSsISSVLKDPDsNPYSLLDt |
| P51116 | S601 | Sugiyama | FXR2 FMR1L2 | RPQRRNRSRRRRNRGNRtDGsIsGDRQPVtVADyIsRAEsQ |
| P51116 | T598 | Sugiyama | FXR2 FMR1L2 | DESRPQRRNRSRRRRNRGNRtDGsIsGDRQPVtVADyIsRA |
| P51116 | T610 | Sugiyama | FXR2 FMR1L2 | RRRNRGNRtDGsIsGDRQPVtVADyIsRAEsQsRQRPPLER |
| P53667 | T508 | GPS6|SIGNOR|ELM|EPSD|PSP | LIMK1 LIMK | EKTQPEGLRSLKKPDRKKRYtVVGNPyWMAPEMINGRSYDE |
| P53671 | T505 | GPS6|SIGNOR|ELM|EPSD|PSP | LIMK2 | MEKATTKKRtLRKNDRKKRYtVVGNPYWMAPEMLNGKSYDE |
| P53671 | T526 | SIGNOR|EPSD | LIMK2 | VVGNPYWMAPEMLNGKSYDEtVDIFSFGIVLCEIIGQVYAD |
| P54652 | S41 | Sugiyama | HSPA2 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P54652 | T229 | Sugiyama | HSPA2 | DVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVSHLAEEFK |
| P57053 | S37 | Sugiyama | H2BC12L H2BFS H2BS1 | KAVTKAQKKDGRKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| P57053 | S39 | Sugiyama | H2BC12L H2BFS H2BS1 | VTKAQKKDGRKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| P58876 | S37 | Sugiyama | H2BC5 H2BFB HIRIP2 HIST1H2BD | KAVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| P58876 | S39 | Sugiyama | H2BC5 H2BFB HIRIP2 HIST1H2BD | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| P60484 | S229 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | PTEN MMAC1 TEP1 | GTCNPQFVVCQLKVKIYSSNsGPtRREDKFMyFEFPQPLPV |
| P60484 | T232 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | PTEN MMAC1 TEP1 | NPQFVVCQLKVKIYSSNsGPtRREDKFMyFEFPQPLPVCGD |
| P60709 | S323 | Sugiyama | ACTB | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P60709 | S52 | Sugiyama | ACTB | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P60709 | T318 | Sugiyama | ACTB | VLsGGttMyPGIADRMQKEItALAPstMKIKIIAPPERKYs |
| P60709 | T324 | Sugiyama | ACTB | tMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGGs |
| P61353 | T94 | Sugiyama | RPL27 | VyNyNHLMPtRysVDIPLDKtVVNKDVFRDPALKRKARREA |
| P61587 | S11 | SIGNOR|EPSD|PSP | RND3 ARHE RHO8 RHOE | __________MKERRAsQKLsSKsIMDPNQNVKCKIVVVGD |
| P61587 | S218 | EPSD|PSP | RND3 ARHE RHO8 RHOE | VNKTNKNVKRNKsQRATKRIsHMPSRPELSAVATDLRKDKA |
| P61587 | S240 | EPSD|PSP | RND3 ARHE RHO8 RHOE | MPSRPELSAVATDLRKDKAKsCTVM________________ |
| P61587 | S7 | EPSD|PSP | RND3 ARHE RHO8 RHOE | ______________MKERRAsQKLsSKsIMDPNQNVKCKIV |
| P61604 | T45 | Sugiyama | HSPE1 | TVTKGGIMLPEKSQGKVLQAtVVAVGsGsKGKGGEIQPVsV |
| P61981 | S46 | Sugiyama | YWHAG | AMKNVtELNEPLsNEERNLLsVAyKNVVGARRSsWRVIsSI |
| P62081 | S119 | Sugiyama | RPS7 | RILPKPTRKSRTKNKQKRPRsRtLtAVHDAILEDLVFPsEI |
| P62081 | T121 | Sugiyama | RPS7 | LPKPTRKSRTKNKQKRPRsRtLtAVHDAILEDLVFPsEIVG |
| P62258 | S148 | Sugiyama | YWHAE | YHRyLAEFAtGNDRKEAAENsLVAyKAAsDIAMtELPPTHP |
| P62258 | S46 | Sugiyama | YWHAE | SMKKVAGMDVELTVEERNLLsVAyKNVIGARRASWRIIssI |
| P62269 | S96 | Sugiyama | RPS18 D6S218E | QYKIPDWFLNRQKDVKDGKysQVLANGLDNKLREDLERLKK |
| P62277 | S12 | Sugiyama | RPS13 | _________MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDD |
| P62277 | S14 | Sugiyama | RPS13 | _______MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDDVK |
| P62280 | T15 | Sugiyama | RPS11 | ______MADIQTERAyQKQPtIFQNKKRVLLGEtGKEKLPR |
| P62316 | T40 | Sugiyama | SNRPD2 SNRPD1 | EEEEFNtGPLsVLtQsVKNNtQVLINCRNNKKLLGRVKAFD |
| P62701 | T247 | Sugiyama | RPS4X CCG2 RPS4 SCAR | VIGKGNKPWIsLPRGKGIRLtIAEERDKRLAAKQSSG____ |
| P62736 | S325 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P62736 | S54 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P62736 | T320 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | VLSGGtTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P62736 | T326 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P62807 | S37 | Sugiyama | H2BC4 H2BFL HIST1H2BC; H2BC6 H2BFH HIST1H2BE; H2BC7 H2BFG HIST1H2BF; H2BC8 H2BFA HIST1H2BG; H2BC10 H2BFK HIST1H2BI | KAVTKAQKKDGKKRKRsRKEsysVyVyKVLKQVHPDTGIss |
| P62807 | S39 | Sugiyama | H2BC4 H2BFL HIST1H2BC; H2BC6 H2BFH HIST1H2BE; H2BC7 H2BFG HIST1H2BF; H2BC8 H2BFA HIST1H2BG; H2BC10 H2BFK HIST1H2BI | VTKAQKKDGKKRKRsRKEsysVyVyKVLKQVHPDTGIssKA |
| P62826 | T32 | Sugiyama | RAN ARA24 OK/SW-cl.81 | KLVLVGDGGtGKttFVKRHLtGEFEKKyVATLGVEVHPLVF |
| P62857 | T28 | Sugiyama | RPS28 | PIKLARVTKVLGRtGsQGQCtQVRVEFMDDtsRsIIRNVKG |
| P62899 | S15 | Sugiyama | RPL31 | ______MAPAKKGGEKKKGRsAINEVVtREytINIHKRIHG |
| P62899 | T26 | Sugiyama | RPL31 | KGGEKKKGRsAINEVVtREytINIHKRIHGVGFKKRAPRAL |
| P62906 | T9 | Sugiyama | RPL10A NEDD6 | ____________MSSKVsRDtLyEAVREVLHGNQRKRRKFL |
| P62917 | S130 | Sugiyama | RPL8 | GTIVCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKL |
| P62917 | T135 | Sugiyama | RPL8 | CLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSGSK |
| P62937 | T157 | Sugiyama | PPIA CYPA | NIVEAMERFGsRNGKTSKKItIADCGQLE____________ |
| P62942 | T22 | Sugiyama | FKBP1A FKBP1 FKBP12 | GVQVEtIsPGDGRtFPKRGQtCVVHytGMLEDGKKFDSSRD |
| P63104 | S45 | Sugiyama | YWHAZ | CMKsVtEQGAELsNEERNLLsVAyKNVVGARRssWRVVssI |
| P63173 | T14 | Sugiyama | RPL38 | _______MPRKIEEIKDFLLtARRKDAKSVKIKKNKDNVKF |
| P63220 | S68 | Sugiyama | RPS21 | GQFKtyAICGAIRRMGEsDDsILRLAKADGIVSKNF_____ |
| P63261 | S323 | Sugiyama | ACTG1 ACTG | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P63261 | S52 | Sugiyama | ACTG1 ACTG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P63261 | T318 | Sugiyama | ACTG1 ACTG | VLsGGttMyPGIADRMQKEItALAPstMKIKIIAPPERKYs |
| P63261 | T324 | Sugiyama | ACTG1 ACTG | tMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGGs |
| P63267 | S324 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P63267 | S53 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P63267 | T319 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | VLSGGtTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P63267 | T325 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P67809 | T108 | Sugiyama | YBX1 NSEP1 YB1 | QtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKGAEAANVtGP |
| P68032 | S325 | Sugiyama | ACTC1 ACTC | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68032 | S54 | Sugiyama | ACTC1 ACTC | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68032 | T320 | Sugiyama | ACTC1 ACTC | VLSGGtTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P68032 | T326 | Sugiyama | ACTC1 ACTC | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P68104 | T432 | Sugiyama | EEF1A1 EEF1A EF1A LENG7 | VEsFSDyPPLGRFAVRDMRQtVAVGVIKAVDKKAAGAGKVT |
| P68133 | S325 | Sugiyama | ACTA1 ACTA | TTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68133 | S54 | Sugiyama | ACTA1 ACTA | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68133 | T320 | Sugiyama | ACTA1 ACTA | VMSGGTTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P68133 | T326 | Sugiyama | ACTA1 ACTA | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P68363 | T73 | Sugiyama | TUBA1B | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| P68363 | T82 | Sugiyama | TUBA1B | VPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANN |
| P68431 | S11 | EPSD | H3C1 H3FA HIST1H3A; H3C2 H3FL HIST1H3B; H3C3 H3FC HIST1H3C; H3C4 H3FB HIST1H3D; H3C6 H3FD HIST1H3E; H3C7 H3FI HIST1H3F; H3C8 H3FH HIST1H3G; H3C10 H3FK HIST1H3H; H3C11 H3FF HIST1H3I; H3C12 H3FJ HIST1H3J | __________MARtKQtARKstGGKAPRKQLATKAARKsAP |
| P68431 | S29 | EPSD | H3C1 H3FA HIST1H3A; H3C2 H3FL HIST1H3B; H3C3 H3FC HIST1H3C; H3C4 H3FB HIST1H3D; H3C6 H3FD HIST1H3E; H3C7 H3FI HIST1H3F; H3C8 H3FH HIST1H3G; H3C10 H3FK HIST1H3H; H3C11 H3FF HIST1H3I; H3C12 H3FJ HIST1H3J | RKstGGKAPRKQLATKAARKsAPATGGVKKPHRyRPGtVAL |
| P68431 | T46 | Sugiyama | H3C1 H3FA HIST1H3A; H3C2 H3FL HIST1H3B; H3C3 H3FC HIST1H3C; H3C4 H3FB HIST1H3D; H3C6 H3FD HIST1H3E; H3C7 H3FI HIST1H3F; H3C8 H3FH HIST1H3G; H3C10 H3FK HIST1H3H; H3C11 H3FF HIST1H3I; H3C12 H3FJ HIST1H3J | ARKsAPATGGVKKPHRyRPGtVALREIRRYQKstELLIRKL |
| P78316 | S29 | Sugiyama | NOP14 C4orf9 NOL14 RES4-25 | ARRKASGAPAGARGGPAKANsNPFEVKVNRQKFQILGRKTR |
| P78345 | S253 | Sugiyama | RPP38 | DtsFEDLsKPKRKLADGRQAsVtLQPLKIKKLIPNPNKIRK |
| P83731 | T83 | Sugiyama | RPL24 | QsEEIQKKRTRRAVKFQRAItGAsLADIMAKRNQKPEVRKA |
| P84098 | S12 | Sugiyama | RPL19 | _________MSMLRLQKRLAssVLRCGKKKVWLDPNEtNEI |
| P84098 | T29 | Sugiyama | RPL19 | RLAssVLRCGKKKVWLDPNEtNEIANANsRQQIRKLIKDGL |
| P84243 | T46 | Sugiyama | H3-3A H3.3A H3F3 H3F3A PP781; H3-3B H3.3B H3F3B | ARKsAPsTGGVKKPHRyRPGtVALREIRRYQKstELLIRKL |
| Q00610 | S146 | Sugiyama | CLTC CLH17 CLTCL2 KIAA0034 | AVYHWSMEGESQPVKMFDRHssLAGCQIINYRTDAKQKWLL |
| Q01105 | T169 | Sugiyama | SET | NKVLSKEFHLNEsGDPssKstEIKWKSGKDLTKRssQTQNK |
| Q02543 | T101 | Sugiyama | RPL18A | WLRYDsRSGtHNMYREyRDLttAGAVtQCyRDMGARHRARA |
| Q02878 | T213 | Sugiyama | RPL6 TXREB1 | FVIAtsTKIDISNVKIPKHLtDAyFKKKKLRKPRHQEGEIF |
| Q04917 | S46 | Sugiyama | YWHAH YWHA1 | AMKAVtELNEPLsNEDRNLLsVAyKNVVGARRSsWRVIsSI |
| Q05397 | S732 | GPS6|ELM|iPTMNet|EPSD|PSP | PTK2 FAK FAK1 | PPKPsRPGYPsPRSSEGFYPsPQHMVQTNHyQVSGYPGSHG |
| Q05639 | T432 | Sugiyama | EEF1A2 EEF1AL STN | VESFSQYPPLGRFAVRDMRQtVAVGVIKNVEKKSGGAGKVT |
| Q06830 | T143 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | EGIsFRGLFIIDDKGILRQItVNDLPVGRsVDEtLRLVQAF |
| Q12965 | T936 | Sugiyama | MYO1E MYO1C | LQVSIGPGLPKNSRPTRRNttQNtGySsGtQNANyPVRAAP |
| Q13310 | T191 | Sugiyama | PABPC4 APP1 PABP4 | GRFKSRKEREAELGAKAKEFtNVyIKNFGEEVDDEsLKELF |
| Q13442 | T18 | Sugiyama | PDAP1 HASPP28 | ___MPKGGRKGGHKGRARQytsPEEIDAQLQAEKQKAREEE |
| Q13442 | T97 | Sugiyama | PDAP1 HASPP28 | VEGLIDIENPNRVAQttKKVtQLDLDGPKELSRREREEIEK |
| Q13464 | S118 | Sugiyama | ROCK1 | TRKVYAMKLLSKFEMIKRSDsAFFWEERDIMAFANSPWVVQ |
| Q13464 | S242 | Sugiyama | ROCK1 | KMNKEGMVRCDtAVGtPDyIsPEVLKSQGGDGYYGRECDWW |
| Q13464 | S296 | Sugiyama | ROCK1 | TPFYADSLVGTYSKIMNHKNsLTFPDDNDISKEAKNLICAF |
| Q13464 | S407 | Sugiyama | ROCK1 | FVGNQLPFVGFTYYSNRRYLsSANPNDNRTssNADKSLQES |
| Q13464 | S417 | Sugiyama | ROCK1 | FTYYSNRRYLsSANPNDNRTssNADKSLQESLQKTIYKLEE |
| Q13464 | S418 | Sugiyama | ROCK1 | TYYSNRRYLsSANPNDNRTssNADKSLQESLQKTIYKLEEQ |
| Q13464 | T219 | Sugiyama | ROCK1 | VKPDNMLLDKSGHLKLADFGtCMKMNKEGMVRCDtAVGtPD |
| Q13464 | T233 | Sugiyama | ROCK1 | KLADFGtCMKMNKEGMVRCDtAVGtPDyIsPEVLKSQGGDG |
| Q13464 | T237 | Sugiyama | ROCK1 | FGtCMKMNKEGMVRCDtAVGtPDyIsPEVLKSQGGDGYYGR |
| Q13464 | Y240 | Sugiyama | ROCK1 | CMKMNKEGMVRCDtAVGtPDyIsPEVLKSQGGDGYYGRECD |
| Q14152 | S584 | Sugiyama | EIF3A EIF3S10 KIAA0139 | EHQRILARRQtIEERKERLEsLNIQREKEELEQREAELQKV |
| Q14160 | S1378 | EPSD|PSP | SCRIB CRIB1 KIAA0147 LAP4 SCRB1 VARTUL | QKyFELEVRVPQAEGPPKRVsLVGADDLRKMQEEEARKLQQ |
| Q14160 | S1508 | EPSD|PSP | SCRIB CRIB1 KIAA0147 LAP4 SCRB1 VARTUL | AELRALEAEKRALWRAARMKsLEQDALRAQMVLSRsQEGRG |
| Q14192 | S257 | Sugiyama | FHL2 DRAL SLIM3 | IsFEERQWHNDCFNCKKCsLsLVGRGFLTERDDILCPDCGK |
| Q14204 | T695 | Sugiyama | DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325 | NHVEGQKLKQDGDsFRMKLNtQEIFDDWARKVQQRNLGVSG |
| Q14247 | T401 | Sugiyama | CTTN EMS1 | RQEQEEARRKLEEQARAKtQtPPVsPAPQPtEERLPssPVy |
| Q14432 | S312 | Sugiyama | PDE3A | sssVVsAEMSGCSSKSHRRtsLPCIPREQLMGHSEWDHKRG |
| Q14432 | T311 | Sugiyama | PDE3A | RsssVVsAEMSGCSSKSHRRtsLPCIPREQLMGHSEWDHKR |
| Q14671 | S709 | Sugiyama | PUM1 KIAA0099 PUMH1 | LGGFGTAVANSNTGSGSRRDsLtGSsDLYKRTSSSLTPIGH |
| Q14CB8 | S422 | EPSD|PSP | ARHGAP19 | TQtPGREPSTSQVQKRARsRsFSGLIKRKVLGNQMMsEKKK |
| Q15080 | S67 | Sugiyama | NCF4 SH3PXD4 | TKGGSKYLIYRRYRQFHALQsKLEERFGPDSKSSALACTLP |
| Q16555 | T555 | SIGNOR|ELM|iPTMNet|EPSD|PSP | DPYSL2 CRMP2 ULIP2 | HQsGFsLsGAQIDDNIPRRTtQRIVAPPGGRANITSLG___ |
| Q16695 | T46 | Sugiyama | H3-4 H3FT HIST3H3 | ARKsAPATGGVKKPHRyRPGtVALREIRRYQKstELLIRKL |
| Q16778 | S39 | Sugiyama | H2BC21 H2BFQ HIST2H2BE | VTKAQKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGIssKA |
| Q3KQU3 | S112 | Sugiyama | MAP7D1 KIAA1187 PARCC1 RPRC1 PP2464 | KsRGPtPPAMGPRDARPPRRssQPsPtAVPAsDsPPtKQEV |
| Q58FF6 | S34 | Sugiyama | HSP90AB4P | IFLQELISNASDALDKIRyEsLtDPsKLDGGKELKIDIIPN |
| Q58FF7 | S58 | Sugiyama | HSP90AB3P HSP90BC | IFLQELISNASDALDKIRyEsLtDPsKLDsGKELKIDIIPN |
| Q58FF8 | S58 | Sugiyama | HSP90AB2P HSP90BB | IFLWELISNASDALDKIRyEsLtDPsKLDsGKELKIDIIPN |
| Q5QNW6 | S37 | Sugiyama | H2BC18 HIST2H2BF | KAVTKVQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| Q5QNW6 | S39 | Sugiyama | H2BC18 HIST2H2BF | VTKVQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q5VTE0 | T432 | Sugiyama | EEF1A1P5 EEF1AL3 | VEsFSDyPPLGRFAVRDMRQtVAVGVIKAVDKKAAGAGKVT |
| Q6DN03 | S39 | Sugiyama | H2BC20P HIST2H2BC | VTKAQKKDGKKRKRSRKEsysIyVyKVLKRVHPDTGIWCKA |
| Q6DRA6 | S39 | Sugiyama | H2BC19P HIST2H2BD | VTKAQKKDGKKRKRSRKEsysIyVyKVLKRVHPDTGIWCKA |
| Q6FI81 | T250 | Sugiyama | CIAPIN1 CUA001 PRO0915 | ASLRAASCGEGKKRKACKNCtCGLAEELEKEKSREQMSSQP |
| Q6NXT2 | T45 | Sugiyama | H3-5 H3F3C | AARKSTPSTCGVKPHRyRPGtVALREIRRYQKstELLIRKL |
| Q6QNY0 | T16 | Sugiyama | BLOC1S3 BLOS3 | _____MASQGRRRRPLRRPEtVVPGEAtEtDsERsAsssEE |
| Q71DI3 | T46 | Sugiyama | H3C15 HIST2H3A; H3C14 H3F2 H3FM HIST2H3C; H3C13 HIST2H3D | ARKsAPATGGVKKPHRyRPGtVALREIRRYQKstELLIRKL |
| Q71U36 | T73 | Sugiyama | TUBA1A TUBA3 | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| Q71U36 | T82 | Sugiyama | TUBA1A TUBA3 | VPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANN |
| Q71UM5 | T74 | Sugiyama | RPS27L | VLCVGCSTVLCQPTGGKARLtEGCsFRRKQH__________ |
| Q7Z417 | S652 | Sugiyama | NUFIP2 KIAA1321 PIG1 | NtLLGsAKEQRYQRGLERNDsWGsFDLRAAIVYHTKEMEsI |
| Q8N257 | S39 | Sugiyama | H2BC26 H2BU1 HIST3H2BB | VTKAQKKDGKKRKRGRKEsysIyVyKVLKQVHPDTGIssKA |
| Q8N264 | S391 | SIGNOR|iPTMNet|EPSD|PSP | ARHGAP24 FILGAP | SRQCSWDKSESPQRSSMNNGsPTALSGSKTNsPKNSVHKLD |
| Q8N264 | S402 | SIGNOR|iPTMNet|EPSD|PSP | ARHGAP24 FILGAP | PQRSSMNNGsPTALSGSKTNsPKNSVHKLDVsRsPPLMVKK |
| Q8N264 | S413 | SIGNOR|iPTMNet|EPSD|PSP | ARHGAP24 FILGAP | TALSGSKTNsPKNSVHKLDVsRsPPLMVKKNPAFNKGSGIV |
| Q8N264 | S415 | SIGNOR|iPTMNet|EPSD|PSP | ARHGAP24 FILGAP | LSGSKTNsPKNSVHKLDVsRsPPLMVKKNPAFNKGSGIVTN |
| Q8N264 | S437 | SIGNOR|iPTMNet|EPSD|PSP | ARHGAP24 FILGAP | PLMVKKNPAFNKGSGIVTNGsFSSSNAEGLEKTQTtPNGSL |
| Q8N264 | S573 | SIGNOR|iPTMNet|EPSD | ARHGAP24 FILGAP | ATWSTSSCEISLPENSNSCRsstttCPEQDFFGGNFEDPVL |
| Q8N264 | S574 | SIGNOR|iPTMNet|EPSD | ARHGAP24 FILGAP | TWSTSSCEISLPENSNSCRsstttCPEQDFFGGNFEDPVLD |
| Q8N264 | T452 | SIGNOR|iPTMNet|EPSD|PSP | ARHGAP24 FILGAP | IVTNGsFSSSNAEGLEKTQTtPNGSLQARRSSSLKVSGTKM |
| Q8N264 | T575 | SIGNOR|iPTMNet|EPSD | ARHGAP24 FILGAP | WSTSSCEISLPENSNSCRsstttCPEQDFFGGNFEDPVLDG |
| Q8N264 | T576 | SIGNOR|iPTMNet|EPSD | ARHGAP24 FILGAP | STSSCEISLPENSNSCRsstttCPEQDFFGGNFEDPVLDGP |
| Q8N264 | T577 | SIGNOR|iPTMNet|EPSD | ARHGAP24 FILGAP | TSSCEISLPENSNSCRsstttCPEQDFFGGNFEDPVLDGPP |
| Q8TD47 | T247 | Sugiyama | RPS4Y2 RPS4Y2P | VIGNGNKPWISLPRGKGIRLtIAEERDKRLAAKQSSG____ |
| Q8WWI1 | T932 | Sugiyama | LMO7 FBX20 FBXO20 KIAA0858 | VtPRPFGsQtRGISsLPRsYtMDDAWKYNGDVEDIKRtPNN |
| Q93079 | S37 | Sugiyama | H2BC9 H2BFJ HIST1H2BH | KAVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| Q93079 | S39 | Sugiyama | H2BC9 H2BFJ HIST1H2BH | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q96IZ0 | S162 | Sugiyama | PAWR PAR4 | PSARKGKGQIEKRKLREKRRstGVVNIPAAECLDEyEDDEA |
| Q96IZ0 | T163 | PSP|Sugiyama | PAWR PAR4 | SARKGKGQIEKRKLREKRRstGVVNIPAAECLDEyEDDEAG |
| Q96JX3 | S450 | Sugiyama | SERAC1 | YTTCWPKTWLAKDCPALRIIsVEYDtSLSDWRARCPMERKS |
| Q96JX3 | T455 | Sugiyama | SERAC1 | PKTWLAKDCPALRIIsVEYDtSLSDWRARCPMERKSIAFRS |
| Q99755 | S479 | Sugiyama | PIP5K1A | PsKKFRSGssFSRRAGssGNsCItyQPsVsGEHKAQVTTKA |
| Q99877 | S37 | Sugiyama | H2BC15 H2BFD HIST1H2BN | KAVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| Q99877 | S39 | Sugiyama | H2BC15 H2BFD HIST1H2BN | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q99879 | S37 | Sugiyama | H2BC14 H2BFE HIST1H2BM | KAINKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| Q99879 | S39 | Sugiyama | H2BC14 H2BFE HIST1H2BM | INKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q99880 | S37 | Sugiyama | H2BC13 H2BFC HIST1H2BL | KAVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| Q99880 | S39 | Sugiyama | H2BC13 H2BFC HIST1H2BL | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q9BQE3 | T73 | Sugiyama | TUBA1C TUBA6 | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| Q9BQE3 | T82 | Sugiyama | TUBA1C TUBA6 | VPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANN |
| Q9HAU0 | S471 | Sugiyama | PLEKHA5 KIAA1686 PEPP2 | MARYPEGYRtLPRNSKTRPEsICSVtPsTHDKTLGPGAEEK |
| Q9NRY4 | S1150 | SIGNOR|EPSD|PSP | ARHGAP35 GRF1 GRLF1 KIAA1722 P190A p190ARHOGAP | sGNGsDsEMDTssLERGRKVsIVSKPVLYRTRCTRLGRFAS |
| Q9NRY4 | S1174 | EPSD|PSP | ARHGAP35 GRF1 GRLF1 KIAA1722 P190A p190ARHOGAP | KPVLYRTRCTRLGRFASYRtsFsVGsDDELGPIRKKEEDQA |
| Q9NRY4 | S1236 | SIGNOR|EPSD|PSP | ARHGAP35 GRF1 GRLF1 KIAA1722 P190A p190ARHOGAP | RNILRsLRRNtKKPKPKPRPsITKATWESNYFGVPLTTVVT |
| Q9NRY4 | T1173 | EPSD|PSP | ARHGAP35 GRF1 GRLF1 KIAA1722 P190A p190ARHOGAP | SKPVLYRTRCTRLGRFASYRtsFsVGsDDELGPIRKKEEDQ |
| Q9NRY4 | T1226 | SIGNOR|EPSD|PSP | ARHGAP35 GRF1 GRLF1 KIAA1722 P190A p190ARHOGAP | PYETDEDPRRRNILRsLRRNtKKPKPKPRPsITKATWESNY |
| Q9UPT6 | S314 | GPS6|SIGNOR|EPSD|PSP | MAPK8IP3 JIP3 KIAA1066 | PLGDYGVGSKNSKRAREKRDsRNMEVQVTQEMRNVSIGMGS |
| Q9UPT6 | S364 | GPS6|SIGNOR|EPSD|PSP | MAPK8IP3 JIP3 KIAA1066 | IIDSTPELDMCPETRLDRtGssPtQGIVNKAFGINTDSLYH |
| Q9UPT6 | S365 | GPS6|SIGNOR|EPSD|PSP | MAPK8IP3 JIP3 KIAA1066 | IDSTPELDMCPETRLDRtGssPtQGIVNKAFGINTDSLYHE |
| Q9UQ35 | S1455 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | PsRRsRsGssPGLRDGsGtPsRHsLsGssPGMKDIPRtPSR |
| Q9UQ35 | S2692 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | ERRSRSPRKPIDsLRDsRsLsysPVERRRPsPQPsPRDQQS |
| Q9UQ35 | S854 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | sHSsssPHPKVKsGtPPRQGsItsPQANEQsVtPQRRsCFE |
| Q9Y2T7 | T143 | Sugiyama | YBX2 CSDA3 MSY2 | QtAIKRNNPRKFLRsVGDGEtVEFDVVEGEKGAEATNVTGP |
| Q9Y2W1 | S379 | Sugiyama | THRAP3 BCLAF2 TRAP150 | DKEQKQTNTDKEKIKEKGsFsDtGLGDGKMKSDsFAPKtDs |
| Q9Y3U8 | S91 | Sugiyama | RPL36 | KFIKKRVGTHIRAKRKREELsNVLAAMRKAAAKKD______ |
| Q9Y5U2 | S109 | Sugiyama | TSSC4 | FSQRsRDIFDCLEGAARRAPsSVAHTSMSDNGGFKRPLAPs |
| Q9Y613 | S1131 | SIGNOR|EPSD|PSP | FHOD1 FHOS FHOS1 | LVQSVTKSSPRALAARERKRsRGNRKsLRRtLKSGLGDDLV |
| Q9Y613 | S1137 | SIGNOR|EPSD|PSP | FHOD1 FHOS FHOS1 | KSSPRALAARERKRsRGNRKsLRRtLKSGLGDDLVQALGLS |
| Q9Y613 | T1141 | SIGNOR|EPSD|PSP | FHOD1 FHOS FHOS1 | RALAARERKRsRGNRKsLRRtLKSGLGDDLVQALGLSKGPG |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cellular Senescence | R-HSA-2559583 | 4.696243e-14 | 13.328 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 8.284373e-12 | 11.082 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 1.684508e-11 | 10.774 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 3.027634e-11 | 10.519 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 4.332679e-11 | 10.363 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 1.461153e-10 | 9.835 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 1.963303e-10 | 9.707 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 2.418618e-10 | 9.616 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 2.873771e-10 | 9.542 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 3.968905e-10 | 9.401 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 4.755243e-10 | 9.323 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 8.374038e-10 | 9.077 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 1.113349e-09 | 8.953 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 1.113349e-09 | 8.953 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 1.171374e-09 | 8.931 | 1 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 1.228120e-09 | 8.911 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 1.661786e-09 | 8.779 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 2.019106e-09 | 8.695 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 2.019106e-09 | 8.695 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 1.947479e-09 | 8.711 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 2.329570e-09 | 8.633 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 2.229504e-09 | 8.652 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 2.855857e-09 | 8.544 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 3.101870e-09 | 8.508 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 3.393801e-09 | 8.469 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 5.971486e-09 | 8.224 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 6.481086e-09 | 8.188 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 8.933875e-09 | 8.049 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 1.028816e-08 | 7.988 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 1.134316e-08 | 7.945 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 1.652095e-08 | 7.782 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 2.061561e-08 | 7.686 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 2.755953e-08 | 7.560 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 2.799457e-08 | 7.553 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 3.553781e-08 | 7.449 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 3.676175e-08 | 7.435 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 3.906719e-08 | 7.408 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 3.906719e-08 | 7.408 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 4.086199e-08 | 7.389 | 0 | 0 |
| Depurination | R-HSA-73927 | 5.127762e-08 | 7.290 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 7.219532e-08 | 7.141 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 7.219532e-08 | 7.141 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 8.655434e-08 | 7.063 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 1.239070e-07 | 6.907 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 1.366693e-07 | 6.864 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 1.620463e-07 | 6.790 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 1.773538e-07 | 6.751 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 1.811233e-07 | 6.742 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 1.811233e-07 | 6.742 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 1.852468e-07 | 6.732 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 2.276851e-07 | 6.643 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 3.399436e-07 | 6.469 | 0 | 0 |
| M Phase | R-HSA-68886 | 3.759796e-07 | 6.425 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 4.005268e-07 | 6.397 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 4.486665e-07 | 6.348 | 1 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 5.063715e-07 | 6.296 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 6.493567e-07 | 6.188 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 6.714566e-07 | 6.173 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 1.137282e-06 | 5.944 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 1.519370e-06 | 5.818 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 1.488161e-06 | 5.827 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 1.765136e-06 | 5.753 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 1.784395e-06 | 5.749 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 1.929549e-06 | 5.715 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 2.087603e-06 | 5.680 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 2.087603e-06 | 5.680 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 2.208537e-06 | 5.656 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 2.621372e-06 | 5.581 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 2.695582e-06 | 5.569 | 1 | 1 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 2.756802e-06 | 5.560 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 3.640982e-06 | 5.439 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 4.088651e-06 | 5.388 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 4.088651e-06 | 5.388 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 6.198461e-06 | 5.208 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 6.238269e-06 | 5.205 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 7.628884e-06 | 5.118 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 7.628884e-06 | 5.118 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 8.829069e-06 | 5.054 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 9.119388e-06 | 5.040 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 9.326862e-06 | 5.030 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 1.211095e-05 | 4.917 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 1.280091e-05 | 4.893 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 1.688751e-05 | 4.772 | 1 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 1.725600e-05 | 4.763 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 1.805997e-05 | 4.743 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 2.122213e-05 | 4.673 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 2.233510e-05 | 4.651 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 2.394498e-05 | 4.621 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 2.624347e-05 | 4.581 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 2.786878e-05 | 4.555 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 2.880024e-05 | 4.541 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 3.226563e-05 | 4.491 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 4.237505e-05 | 4.373 | 1 | 0 |
| Semaphorin interactions | R-HSA-373755 | 4.366631e-05 | 4.360 | 1 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 5.902017e-05 | 4.229 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 6.101271e-05 | 4.215 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 6.244657e-05 | 4.204 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 7.794046e-05 | 4.108 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 9.101846e-05 | 4.041 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 1.072924e-04 | 3.969 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 1.096225e-04 | 3.960 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 1.198099e-04 | 3.922 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 1.232259e-04 | 3.909 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 1.564545e-04 | 3.806 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 1.564545e-04 | 3.806 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 1.564545e-04 | 3.806 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 1.472027e-04 | 3.832 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 1.876611e-04 | 3.727 | 1 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 1.931328e-04 | 3.714 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 1.931328e-04 | 3.714 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 1.962965e-04 | 3.707 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 2.310471e-04 | 3.636 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 2.369368e-04 | 3.625 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 2.444668e-04 | 3.612 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 2.794666e-04 | 3.554 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 2.807070e-04 | 3.552 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 3.129632e-04 | 3.505 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 3.222255e-04 | 3.492 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 3.231575e-04 | 3.491 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 3.386625e-04 | 3.470 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 3.391480e-04 | 3.470 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 3.702146e-04 | 3.432 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 5.200075e-04 | 3.284 | 1 | 1 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 5.363233e-04 | 3.271 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 5.408897e-04 | 3.267 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 6.282219e-04 | 3.202 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 6.527753e-04 | 3.185 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 6.605958e-04 | 3.180 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 7.594576e-04 | 3.119 | 1 | 0 |
| Deubiquitination | R-HSA-5688426 | 7.688026e-04 | 3.114 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 7.703666e-04 | 3.113 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 7.805330e-04 | 3.108 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 8.348518e-04 | 3.078 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 1.052321e-03 | 2.978 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 1.055701e-03 | 2.976 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 1.060083e-03 | 2.975 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 1.071797e-03 | 2.970 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 1.209252e-03 | 2.917 | 1 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 1.303936e-03 | 2.885 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 1.316846e-03 | 2.880 | 1 | 1 |
| Mitotic Prometaphase | R-HSA-68877 | 1.365444e-03 | 2.865 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 1.773486e-03 | 2.751 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 1.946908e-03 | 2.711 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 2.129368e-03 | 2.672 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 2.153696e-03 | 2.667 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 2.224062e-03 | 2.653 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 2.227145e-03 | 2.652 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 2.230936e-03 | 2.652 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 2.345978e-03 | 2.630 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 2.375492e-03 | 2.624 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 2.999616e-03 | 2.523 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 2.745668e-03 | 2.561 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 2.999616e-03 | 2.523 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 2.999616e-03 | 2.523 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 2.764788e-03 | 2.558 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 3.236839e-03 | 2.490 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 3.236839e-03 | 2.490 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 3.728307e-03 | 2.428 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 3.790655e-03 | 2.421 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 3.862883e-03 | 2.413 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 4.003293e-03 | 2.398 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 4.116721e-03 | 2.385 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 4.239313e-03 | 2.373 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 4.601793e-03 | 2.337 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 5.104824e-03 | 2.292 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 5.191775e-03 | 2.285 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 5.473864e-03 | 2.262 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 5.549657e-03 | 2.256 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 5.601538e-03 | 2.252 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 6.544968e-03 | 2.184 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 6.212117e-03 | 2.207 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 5.731257e-03 | 2.242 | 1 | 0 |
| Apoptosis | R-HSA-109581 | 5.900404e-03 | 2.229 | 1 | 0 |
| Rap1 signalling | R-HSA-392517 | 5.919028e-03 | 2.228 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 5.816540e-03 | 2.235 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 5.874491e-03 | 2.231 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 6.636830e-03 | 2.178 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 6.636830e-03 | 2.178 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 6.645730e-03 | 2.177 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 7.187058e-03 | 2.143 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 7.275085e-03 | 2.138 | 1 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 7.792973e-03 | 2.108 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 8.052337e-03 | 2.094 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 8.217563e-03 | 2.085 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 8.217563e-03 | 2.085 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 8.384417e-03 | 2.077 | 1 | 1 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 8.475077e-03 | 2.072 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 8.733453e-03 | 2.059 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 8.845740e-03 | 2.053 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 8.923237e-03 | 2.049 | 0 | 0 |
| TGFBR3 regulates FGF2 signaling | R-HSA-9839397 | 9.001955e-03 | 2.046 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 9.365901e-03 | 2.028 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 1.009240e-02 | 1.996 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 1.079469e-02 | 1.967 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 1.132102e-02 | 1.946 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 1.141537e-02 | 1.943 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 1.210369e-02 | 1.917 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 1.210369e-02 | 1.917 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 1.352449e-02 | 1.869 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 1.239045e-02 | 1.907 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 1.258627e-02 | 1.900 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 1.298212e-02 | 1.887 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 1.263402e-02 | 1.898 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 1.380994e-02 | 1.860 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 1.433699e-02 | 1.844 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 1.471281e-02 | 1.832 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 1.492401e-02 | 1.826 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 1.533550e-02 | 1.814 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 1.533550e-02 | 1.814 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 1.551887e-02 | 1.809 | 0 | 0 |
| Potassium transport channels | R-HSA-1296067 | 1.551887e-02 | 1.809 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 1.567602e-02 | 1.805 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 1.680592e-02 | 1.775 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 1.759261e-02 | 1.755 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 1.781100e-02 | 1.749 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 1.798027e-02 | 1.745 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 1.802396e-02 | 1.744 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 1.847505e-02 | 1.733 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 1.953615e-02 | 1.709 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 1.953615e-02 | 1.709 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 2.038372e-02 | 1.691 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 2.089198e-02 | 1.680 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 2.110317e-02 | 1.676 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 2.347043e-02 | 1.629 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 2.353749e-02 | 1.628 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 2.407682e-02 | 1.618 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 2.826098e-02 | 1.549 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 2.407682e-02 | 1.618 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 2.499759e-02 | 1.602 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 2.400884e-02 | 1.620 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 2.407682e-02 | 1.618 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 2.400884e-02 | 1.620 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 2.420021e-02 | 1.616 | 1 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 2.718354e-02 | 1.566 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 2.868915e-02 | 1.542 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 2.407682e-02 | 1.618 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 2.709373e-02 | 1.567 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 2.709373e-02 | 1.567 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 3.122179e-02 | 1.506 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 3.128486e-02 | 1.505 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 3.128486e-02 | 1.505 | 0 | 0 |
| Immune System | R-HSA-168256 | 3.183651e-02 | 1.497 | 1 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 3.284691e-02 | 1.484 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 3.284691e-02 | 1.484 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 3.284691e-02 | 1.484 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 3.284691e-02 | 1.484 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 3.284691e-02 | 1.484 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 3.324209e-02 | 1.478 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 3.324209e-02 | 1.478 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 3.369948e-02 | 1.472 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 3.446851e-02 | 1.463 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 3.446851e-02 | 1.463 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 3.446851e-02 | 1.463 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 3.491002e-02 | 1.457 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 3.491002e-02 | 1.457 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 3.726946e-02 | 1.429 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 3.770241e-02 | 1.424 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 3.782247e-02 | 1.422 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 3.830936e-02 | 1.417 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 3.958396e-02 | 1.402 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 4.044556e-02 | 1.393 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 4.044556e-02 | 1.393 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 4.044556e-02 | 1.393 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 4.044556e-02 | 1.393 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 4.044556e-02 | 1.393 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 4.044556e-02 | 1.393 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 4.337057e-02 | 1.363 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 4.423439e-02 | 1.354 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 4.580491e-02 | 1.339 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 4.887925e-02 | 1.311 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 4.690932e-02 | 1.329 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 5.561890e-02 | 1.255 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 4.718850e-02 | 1.326 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 5.063060e-02 | 1.296 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 4.612143e-02 | 1.336 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 5.387268e-02 | 1.269 | 0 | 0 |
| S Phase | R-HSA-69242 | 5.297853e-02 | 1.276 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 5.387268e-02 | 1.269 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 4.773616e-02 | 1.321 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 5.495921e-02 | 1.260 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 4.783179e-02 | 1.320 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 5.003105e-02 | 1.301 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 4.690932e-02 | 1.329 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 5.384818e-02 | 1.269 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 5.825901e-02 | 1.235 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 5.906300e-02 | 1.229 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 5.975899e-02 | 1.224 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 5.975899e-02 | 1.224 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 6.124848e-02 | 1.213 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 6.124848e-02 | 1.213 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 6.355015e-02 | 1.197 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 6.749346e-02 | 1.171 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 6.749346e-02 | 1.171 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 6.749346e-02 | 1.171 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 6.762572e-02 | 1.170 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 6.773604e-02 | 1.169 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 7.009785e-02 | 1.154 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 7.145455e-02 | 1.146 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 7.151331e-02 | 1.146 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 7.151331e-02 | 1.146 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 7.151331e-02 | 1.146 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 7.260424e-02 | 1.139 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 8.951438e-02 | 1.048 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 8.951438e-02 | 1.048 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 8.951438e-02 | 1.048 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 8.951438e-02 | 1.048 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 8.951438e-02 | 1.048 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 8.951438e-02 | 1.048 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 8.951438e-02 | 1.048 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 8.951438e-02 | 1.048 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 8.086262e-02 | 1.092 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 8.086262e-02 | 1.092 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 9.496415e-02 | 1.022 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 9.496415e-02 | 1.022 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 9.513634e-02 | 1.022 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 8.435380e-02 | 1.074 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 8.435380e-02 | 1.074 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 9.116775e-02 | 1.040 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 9.016202e-02 | 1.045 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 9.914226e-02 | 1.004 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 7.536076e-02 | 1.123 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 8.435380e-02 | 1.074 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 9.116775e-02 | 1.040 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 7.737046e-02 | 1.111 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 8.358511e-02 | 1.078 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 9.496415e-02 | 1.022 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 8.435380e-02 | 1.074 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 9.444608e-02 | 1.025 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 8.358511e-02 | 1.078 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 8.358511e-02 | 1.078 | 0 | 0 |
| Astrocytic Glutamate-Glutamine Uptake And Metabolism | R-HSA-210455 | 9.496415e-02 | 1.022 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 9.496415e-02 | 1.022 | 0 | 0 |
| Neurotransmitter uptake and metabolism In glial cells | R-HSA-112313 | 9.496415e-02 | 1.022 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 9.116775e-02 | 1.040 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 9.116775e-02 | 1.040 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 8.837873e-02 | 1.054 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 8.951438e-02 | 1.048 | 0 | 0 |
| PKA activation | R-HSA-163615 | 9.513634e-02 | 1.022 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 9.513634e-02 | 1.022 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 7.737046e-02 | 1.111 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 8.605729e-02 | 1.065 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 1.003763e-01 | 0.998 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 8.605729e-02 | 1.065 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 7.691259e-02 | 1.114 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 7.780035e-02 | 1.109 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 8.870100e-02 | 1.052 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 7.759070e-02 | 1.110 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 8.154174e-02 | 1.089 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 8.086262e-02 | 1.092 | 0 | 0 |
| Phase 3 - rapid repolarisation | R-HSA-5576890 | 8.086262e-02 | 1.092 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 8.977971e-02 | 1.047 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 9.496415e-02 | 1.022 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 1.003763e-01 | 0.998 | 1 | 1 |
| Glucose metabolism | R-HSA-70326 | 9.318681e-02 | 1.031 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 7.816039e-02 | 1.107 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 1.021078e-01 | 0.991 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 1.022715e-01 | 0.990 | 0 | 0 |
| Kinesins | R-HSA-983189 | 1.036362e-01 | 0.984 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 1.045879e-01 | 0.981 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 1.045879e-01 | 0.981 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 1.055505e-01 | 0.977 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 1.055505e-01 | 0.977 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 1.055505e-01 | 0.977 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 1.064882e-01 | 0.973 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 1.064882e-01 | 0.973 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 1.090087e-01 | 0.963 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 1.097031e-01 | 0.960 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 1.097031e-01 | 0.960 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 1.097031e-01 | 0.960 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 1.127785e-01 | 0.948 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 1.127785e-01 | 0.948 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 1.127785e-01 | 0.948 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 1.127785e-01 | 0.948 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 1.127785e-01 | 0.948 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 1.131048e-01 | 0.947 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 1.131048e-01 | 0.947 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 1.131048e-01 | 0.947 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 1.131048e-01 | 0.947 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 1.134943e-01 | 0.945 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 1.143915e-01 | 0.942 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 1.143915e-01 | 0.942 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 1.143915e-01 | 0.942 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 1.143915e-01 | 0.942 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 1.143915e-01 | 0.942 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 1.143915e-01 | 0.942 | 0 | 0 |
| SMAD4 MH2 Domain Mutants in Cancer | R-HSA-3311021 | 1.312241e-01 | 0.882 | 0 | 0 |
| Intestinal infectious diseases | R-HSA-8942233 | 1.312241e-01 | 0.882 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 1.312241e-01 | 0.882 | 0 | 0 |
| TWIK-releated acid-sensitive K+ channel (TASK) | R-HSA-1299316 | 1.312241e-01 | 0.882 | 0 | 0 |
| Loss of Function of SMAD4 in Cancer | R-HSA-3304347 | 1.312241e-01 | 0.882 | 0 | 0 |
| MyD88 deficiency (TLR5) | R-HSA-5602680 | 1.312241e-01 | 0.882 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 1.312241e-01 | 0.882 | 0 | 0 |
| Defective ABCC9 causes CMD10, ATFB12 and Cantu syndrome | R-HSA-5678420 | 1.312241e-01 | 0.882 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 1.312241e-01 | 0.882 | 0 | 0 |
| SMAD2/3 MH2 Domain Mutants in Cancer | R-HSA-3315487 | 1.312241e-01 | 0.882 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 1.710256e-01 | 0.767 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 1.710256e-01 | 0.767 | 0 | 0 |
| Interaction between PHLDA1 and AURKA | R-HSA-8854521 | 1.710256e-01 | 0.767 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 1.710256e-01 | 0.767 | 0 | 0 |
| HHAT G278V doesn't palmitoylate Hh-Np | R-HSA-5658034 | 1.710256e-01 | 0.767 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 1.710256e-01 | 0.767 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 1.710256e-01 | 0.767 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 1.710256e-01 | 0.767 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 1.710256e-01 | 0.767 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 1.710256e-01 | 0.767 | 0 | 0 |
| Mitotic Metaphase/Anaphase Transition | R-HSA-68881 | 1.710256e-01 | 0.767 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 1.710256e-01 | 0.767 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 1.710256e-01 | 0.767 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 1.710256e-01 | 0.767 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 1.710256e-01 | 0.767 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 1.249917e-01 | 0.903 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 1.249917e-01 | 0.903 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 1.407488e-01 | 0.852 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 1.568995e-01 | 0.804 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 1.568995e-01 | 0.804 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 1.568995e-01 | 0.804 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 1.568995e-01 | 0.804 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 1.733750e-01 | 0.761 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 1.733750e-01 | 0.761 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 1.733750e-01 | 0.761 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 1.733750e-01 | 0.761 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 1.733750e-01 | 0.761 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 1.245265e-01 | 0.905 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 1.245265e-01 | 0.905 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 1.245265e-01 | 0.905 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 1.349718e-01 | 0.870 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 1.349718e-01 | 0.870 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 1.349718e-01 | 0.870 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 1.567087e-01 | 0.805 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 1.208904e-01 | 0.918 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 1.679580e-01 | 0.775 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 1.679580e-01 | 0.775 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 1.541757e-01 | 0.812 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 1.540288e-01 | 0.812 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 1.614449e-01 | 0.792 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 1.614449e-01 | 0.792 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 1.379267e-01 | 0.860 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 1.371224e-01 | 0.863 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 1.371224e-01 | 0.863 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 1.249917e-01 | 0.903 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 1.249917e-01 | 0.903 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 1.719757e-01 | 0.765 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 1.259581e-01 | 0.900 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 1.288992e-01 | 0.890 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 1.567087e-01 | 0.805 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 1.407488e-01 | 0.852 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 1.733750e-01 | 0.761 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 1.158696e-01 | 0.936 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 1.371224e-01 | 0.863 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 1.208904e-01 | 0.918 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 1.407488e-01 | 0.852 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 1.407488e-01 | 0.852 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 1.245265e-01 | 0.905 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 1.504047e-01 | 0.823 | 0 | 0 |
| Defective ABCC8 can cause hypo- and hyper-glycemias | R-HSA-5683177 | 1.710256e-01 | 0.767 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 1.710256e-01 | 0.767 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 1.407488e-01 | 0.852 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 1.288992e-01 | 0.890 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 1.629871e-01 | 0.788 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 1.396405e-01 | 0.855 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 1.201720e-01 | 0.920 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 1.372718e-01 | 0.862 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 1.679580e-01 | 0.775 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 1.371224e-01 | 0.863 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 1.371224e-01 | 0.863 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 1.685053e-01 | 0.773 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 1.733750e-01 | 0.761 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 1.733750e-01 | 0.761 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 1.394053e-01 | 0.856 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 1.201720e-01 | 0.920 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 1.201720e-01 | 0.920 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 1.312241e-01 | 0.882 | 0 | 0 |
| DSCAM interactions | R-HSA-376172 | 1.710256e-01 | 0.767 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 1.249917e-01 | 0.903 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 1.349718e-01 | 0.870 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 1.457063e-01 | 0.837 | 0 | 0 |
| Estrogen biosynthesis | R-HSA-193144 | 1.733750e-01 | 0.761 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 1.288992e-01 | 0.890 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 1.540288e-01 | 0.812 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 1.389103e-01 | 0.857 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 1.158696e-01 | 0.936 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 1.349718e-01 | 0.870 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 1.679580e-01 | 0.775 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 1.772264e-01 | 0.751 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 1.794333e-01 | 0.746 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 1.794333e-01 | 0.746 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 1.794333e-01 | 0.746 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 1.801394e-01 | 0.744 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 1.801394e-01 | 0.744 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 1.811317e-01 | 0.742 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 1.811317e-01 | 0.742 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 1.811317e-01 | 0.742 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 1.811317e-01 | 0.742 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 1.811317e-01 | 0.742 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 1.836617e-01 | 0.736 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 1.845166e-01 | 0.734 | 0 | 0 |
| Defective GCLC causes HAGGSD | R-HSA-5578999 | 2.090059e-01 | 0.680 | 0 | 0 |
| IRAK4 deficiency (TLR5) | R-HSA-5603037 | 2.090059e-01 | 0.680 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 2.090059e-01 | 0.680 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 2.452483e-01 | 0.610 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 2.452483e-01 | 0.610 | 0 | 0 |
| ATP sensitive Potassium channels | R-HSA-1296025 | 2.452483e-01 | 0.610 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 2.452483e-01 | 0.610 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 2.798322e-01 | 0.553 | 0 | 0 |
| IRS activation | R-HSA-74713 | 2.798322e-01 | 0.553 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 2.798322e-01 | 0.553 | 0 | 0 |
| NOSIP mediated eNOS trafficking | R-HSA-203754 | 2.798322e-01 | 0.553 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 2.798322e-01 | 0.553 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 2.798322e-01 | 0.553 | 0 | 0 |
| Defective SLC1A3 causes episodic ataxia 6 (EA6) | R-HSA-5619062 | 2.798322e-01 | 0.553 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 3.128335e-01 | 0.505 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 3.128335e-01 | 0.505 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 3.128335e-01 | 0.505 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 3.128335e-01 | 0.505 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 3.128335e-01 | 0.505 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 3.128335e-01 | 0.505 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 3.128335e-01 | 0.505 | 0 | 0 |
| Signaling by RNF43 mutants | R-HSA-5340588 | 3.128335e-01 | 0.505 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 1.901116e-01 | 0.721 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 1.901116e-01 | 0.721 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 2.070510e-01 | 0.684 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 3.443243e-01 | 0.463 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 3.443243e-01 | 0.463 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 2.241396e-01 | 0.649 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 2.241396e-01 | 0.649 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 2.241396e-01 | 0.649 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 2.413282e-01 | 0.617 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 2.413282e-01 | 0.617 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 3.743739e-01 | 0.427 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 3.743739e-01 | 0.427 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 3.743739e-01 | 0.427 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 3.743739e-01 | 0.427 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 3.743739e-01 | 0.427 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 3.743739e-01 | 0.427 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 3.743739e-01 | 0.427 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 3.743739e-01 | 0.427 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 2.585719e-01 | 0.587 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 2.029796e-01 | 0.693 | 1 | 1 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 2.029796e-01 | 0.693 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 2.029796e-01 | 0.693 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 2.029796e-01 | 0.693 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 2.758297e-01 | 0.559 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 2.758297e-01 | 0.559 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 2.150104e-01 | 0.668 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 2.150104e-01 | 0.668 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 2.271868e-01 | 0.644 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 3.102411e-01 | 0.508 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 3.102411e-01 | 0.508 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 2.095051e-01 | 0.679 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 2.769773e-01 | 0.558 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 2.896083e-01 | 0.538 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 2.490788e-01 | 0.604 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 3.611336e-01 | 0.442 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 3.611336e-01 | 0.442 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 3.022797e-01 | 0.520 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 2.424170e-01 | 0.615 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 2.424170e-01 | 0.615 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 3.657255e-01 | 0.437 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 2.301986e-01 | 0.638 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 2.301986e-01 | 0.638 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 3.318822e-01 | 0.479 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 2.889805e-01 | 0.539 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 3.529212e-01 | 0.452 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 3.050396e-01 | 0.516 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 3.443024e-01 | 0.463 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 3.443024e-01 | 0.463 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 2.758297e-01 | 0.559 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 2.758297e-01 | 0.559 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 2.150104e-01 | 0.668 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 2.519010e-01 | 0.599 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 2.029796e-01 | 0.693 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 3.102411e-01 | 0.508 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 1.999063e-01 | 0.699 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 3.273299e-01 | 0.485 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 1.901116e-01 | 0.721 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 2.536996e-01 | 0.596 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 1.999063e-01 | 0.699 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 3.043491e-01 | 0.517 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 1.911140e-01 | 0.719 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 2.930641e-01 | 0.533 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 2.644026e-01 | 0.578 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 2.344636e-01 | 0.630 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 2.241396e-01 | 0.649 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 2.241396e-01 | 0.649 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 2.519010e-01 | 0.599 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 3.134057e-01 | 0.504 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 3.134057e-01 | 0.504 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 2.585719e-01 | 0.587 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 3.443024e-01 | 0.463 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 2.413282e-01 | 0.617 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 2.930641e-01 | 0.533 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 1.901116e-01 | 0.721 | 0 | 0 |
| mRNA Editing: C to U Conversion | R-HSA-72200 | 3.743739e-01 | 0.427 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 3.743739e-01 | 0.427 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 1.924629e-01 | 0.716 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 3.443024e-01 | 0.463 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 3.316174e-01 | 0.479 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 1.877852e-01 | 0.726 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 1.999063e-01 | 0.699 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 2.394898e-01 | 0.621 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 2.290760e-01 | 0.640 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 2.290760e-01 | 0.640 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 3.109094e-01 | 0.507 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 3.407613e-01 | 0.468 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 2.896083e-01 | 0.538 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 2.452483e-01 | 0.610 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 2.798322e-01 | 0.553 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 2.798322e-01 | 0.553 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 2.241396e-01 | 0.649 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 2.758297e-01 | 0.559 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 2.290760e-01 | 0.640 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 2.467143e-01 | 0.608 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 1.911140e-01 | 0.719 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 3.457869e-01 | 0.461 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 2.769773e-01 | 0.558 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 3.443243e-01 | 0.463 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 2.930641e-01 | 0.533 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 3.273299e-01 | 0.485 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 2.896083e-01 | 0.538 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 3.102411e-01 | 0.508 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 2.397902e-01 | 0.620 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 3.407613e-01 | 0.468 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 2.769773e-01 | 0.558 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 2.617659e-01 | 0.582 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 2.452483e-01 | 0.610 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 2.798322e-01 | 0.553 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 2.798322e-01 | 0.553 | 0 | 0 |
| Synthesis of PS | R-HSA-1483101 | 3.128335e-01 | 0.505 | 0 | 0 |
| Formation of the Editosome | R-HSA-75094 | 3.128335e-01 | 0.505 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 3.128335e-01 | 0.505 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 3.128335e-01 | 0.505 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 1.901116e-01 | 0.721 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 1.901116e-01 | 0.721 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 3.443243e-01 | 0.463 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 2.930641e-01 | 0.533 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 2.271868e-01 | 0.644 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 3.639426e-01 | 0.439 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 2.878447e-01 | 0.541 | 1 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 3.704854e-01 | 0.431 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 2.769773e-01 | 0.558 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 3.743739e-01 | 0.427 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 2.731081e-01 | 0.564 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 3.743739e-01 | 0.427 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 2.821904e-01 | 0.549 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 2.008944e-01 | 0.697 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 2.413282e-01 | 0.617 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 1.911140e-01 | 0.719 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 2.967220e-01 | 0.528 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 2.150104e-01 | 0.668 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 2.271868e-01 | 0.644 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 3.022797e-01 | 0.520 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 2.397902e-01 | 0.620 | 0 | 0 |
| CASP5-mediated substrate cleavage | R-HSA-9960525 | 2.090059e-01 | 0.680 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 2.452483e-01 | 0.610 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 2.798322e-01 | 0.553 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 3.128335e-01 | 0.505 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 3.128335e-01 | 0.505 | 0 | 0 |
| Abacavir transmembrane transport | R-HSA-2161517 | 3.443243e-01 | 0.463 | 0 | 0 |
| Phase 2 - plateau phase | R-HSA-5576893 | 2.585719e-01 | 0.587 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 1.911140e-01 | 0.719 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 2.769773e-01 | 0.558 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 2.769773e-01 | 0.558 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 3.443024e-01 | 0.463 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 2.490788e-01 | 0.604 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 3.022797e-01 | 0.520 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 3.739627e-01 | 0.427 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 2.846902e-01 | 0.546 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 2.153280e-01 | 0.667 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 3.128335e-01 | 0.505 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 1.906388e-01 | 0.720 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 3.276826e-01 | 0.485 | 0 | 0 |
| Histamine receptors | R-HSA-390650 | 2.090059e-01 | 0.680 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 2.241396e-01 | 0.649 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 2.769773e-01 | 0.558 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 2.769773e-01 | 0.558 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 3.403852e-01 | 0.468 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 2.253720e-01 | 0.647 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 2.585719e-01 | 0.587 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 2.930641e-01 | 0.533 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 2.338503e-01 | 0.631 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 2.797229e-01 | 0.553 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 2.797229e-01 | 0.553 | 0 | 0 |
| CASP4-mediated substrate cleavage | R-HSA-9960519 | 2.090059e-01 | 0.680 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 2.798322e-01 | 0.553 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 3.443243e-01 | 0.463 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 3.743739e-01 | 0.427 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 3.743739e-01 | 0.427 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 2.095051e-01 | 0.679 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 3.611336e-01 | 0.442 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 3.134057e-01 | 0.504 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 2.029796e-01 | 0.693 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 2.095051e-01 | 0.679 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 2.536996e-01 | 0.596 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 3.443024e-01 | 0.463 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 2.896083e-01 | 0.538 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 2.932660e-01 | 0.533 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 2.774457e-01 | 0.557 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 3.102411e-01 | 0.508 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 2.490788e-01 | 0.604 | 0 | 0 |
| Toxicity of botulinum toxin type C (botC) | R-HSA-5250971 | 2.798322e-01 | 0.553 | 0 | 0 |
| Toxicity of botulinum toxin type E (botE) | R-HSA-5250992 | 3.128335e-01 | 0.505 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 3.128335e-01 | 0.505 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 3.443243e-01 | 0.463 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 2.241396e-01 | 0.649 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 2.585719e-01 | 0.587 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 3.273299e-01 | 0.485 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 2.769773e-01 | 0.558 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 2.390283e-01 | 0.622 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 3.273299e-01 | 0.485 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 2.745188e-01 | 0.561 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 2.192317e-01 | 0.659 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 2.896083e-01 | 0.538 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 3.276826e-01 | 0.485 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 1.938720e-01 | 0.712 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 1.901116e-01 | 0.721 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 2.930641e-01 | 0.533 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 3.657255e-01 | 0.437 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 2.930641e-01 | 0.533 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 2.694356e-01 | 0.570 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 3.102411e-01 | 0.508 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 3.276826e-01 | 0.485 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 2.930641e-01 | 0.533 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 3.770374e-01 | 0.424 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 3.778007e-01 | 0.423 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 3.778007e-01 | 0.423 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 3.778007e-01 | 0.423 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 3.783382e-01 | 0.422 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 3.783382e-01 | 0.422 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 3.783382e-01 | 0.422 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 3.783382e-01 | 0.422 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 3.783382e-01 | 0.422 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 3.783382e-01 | 0.422 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 3.783382e-01 | 0.422 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 3.844655e-01 | 0.415 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 3.908971e-01 | 0.408 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 3.908971e-01 | 0.408 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 3.921666e-01 | 0.407 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 3.942836e-01 | 0.404 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 3.942836e-01 | 0.404 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 3.949467e-01 | 0.403 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 3.958183e-01 | 0.403 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 4.004353e-01 | 0.397 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 4.004353e-01 | 0.397 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 4.030480e-01 | 0.395 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 4.030480e-01 | 0.395 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 4.030480e-01 | 0.395 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 4.030480e-01 | 0.395 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 4.030480e-01 | 0.395 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 4.030480e-01 | 0.395 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 4.030480e-01 | 0.395 | 0 | 0 |
| Co-stimulation by ICOS | R-HSA-9927354 | 4.030480e-01 | 0.395 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 4.030480e-01 | 0.395 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 4.030480e-01 | 0.395 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 4.030480e-01 | 0.395 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 4.030480e-01 | 0.395 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 4.030480e-01 | 0.395 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 4.030480e-01 | 0.395 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 4.033912e-01 | 0.394 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 4.033912e-01 | 0.394 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 4.033912e-01 | 0.394 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 4.034927e-01 | 0.394 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 4.034927e-01 | 0.394 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 4.034927e-01 | 0.394 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 4.053995e-01 | 0.392 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 4.053995e-01 | 0.392 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 4.060014e-01 | 0.391 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 4.065063e-01 | 0.391 | 1 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 4.105640e-01 | 0.387 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 4.105640e-01 | 0.387 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 4.158103e-01 | 0.381 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 4.252896e-01 | 0.371 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 4.261937e-01 | 0.370 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 4.261937e-01 | 0.370 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 4.266260e-01 | 0.370 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 4.266260e-01 | 0.370 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 4.266260e-01 | 0.370 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 4.266260e-01 | 0.370 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 4.266260e-01 | 0.370 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 4.266260e-01 | 0.370 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 4.266260e-01 | 0.370 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 4.266260e-01 | 0.370 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 4.281447e-01 | 0.368 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 4.281781e-01 | 0.368 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 4.304096e-01 | 0.366 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 4.304096e-01 | 0.366 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 4.304096e-01 | 0.366 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 4.304096e-01 | 0.366 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 4.304096e-01 | 0.366 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 4.304096e-01 | 0.366 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 4.304096e-01 | 0.366 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 4.304096e-01 | 0.366 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 4.304096e-01 | 0.366 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 4.304096e-01 | 0.366 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 4.304096e-01 | 0.366 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 4.304096e-01 | 0.366 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 4.304096e-01 | 0.366 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 4.304096e-01 | 0.366 | 0 | 0 |
| Toxicity of botulinum toxin type A (botA) | R-HSA-5250968 | 4.304096e-01 | 0.366 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 4.304096e-01 | 0.366 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 4.316698e-01 | 0.365 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 4.316698e-01 | 0.365 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 4.403853e-01 | 0.356 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 4.403853e-01 | 0.356 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 4.422356e-01 | 0.354 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 4.424554e-01 | 0.354 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 4.424554e-01 | 0.354 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 4.424554e-01 | 0.354 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 4.506731e-01 | 0.346 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 4.525238e-01 | 0.344 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 4.525238e-01 | 0.344 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 4.541872e-01 | 0.343 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 4.541872e-01 | 0.343 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 4.565187e-01 | 0.341 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 4.565187e-01 | 0.341 | 0 | 0 |
| TET1,2,3 and TDG demethylate DNA | R-HSA-5221030 | 4.565187e-01 | 0.341 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 4.565187e-01 | 0.341 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 4.565187e-01 | 0.341 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 4.565187e-01 | 0.341 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 4.565187e-01 | 0.341 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 4.565187e-01 | 0.341 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 4.565187e-01 | 0.341 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 4.565187e-01 | 0.341 | 0 | 0 |
| Metal sequestration by antimicrobial proteins | R-HSA-6799990 | 4.565187e-01 | 0.341 | 0 | 0 |
| Tandem pore domain potassium channels | R-HSA-1296346 | 4.565187e-01 | 0.341 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 4.565187e-01 | 0.341 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 4.580398e-01 | 0.339 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 4.580398e-01 | 0.339 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 4.580398e-01 | 0.339 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 4.671670e-01 | 0.331 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 4.671670e-01 | 0.331 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 4.682948e-01 | 0.329 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 4.689193e-01 | 0.329 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 4.733685e-01 | 0.325 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 4.733685e-01 | 0.325 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 4.733685e-01 | 0.325 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 4.733685e-01 | 0.325 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 4.764629e-01 | 0.322 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 4.772499e-01 | 0.321 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 4.814324e-01 | 0.317 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 4.814324e-01 | 0.317 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 4.814324e-01 | 0.317 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 4.814324e-01 | 0.317 | 0 | 0 |
| Presynaptic depolarization and calcium channel opening | R-HSA-112308 | 4.814324e-01 | 0.317 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 4.814324e-01 | 0.317 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 4.814324e-01 | 0.317 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 4.814324e-01 | 0.317 | 0 | 0 |
| FGFR2b ligand binding and activation | R-HSA-190377 | 4.814324e-01 | 0.317 | 0 | 0 |
| FGFRL1 modulation of FGFR1 signaling | R-HSA-5658623 | 4.814324e-01 | 0.317 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 4.814324e-01 | 0.317 | 0 | 0 |
| Cholesterol biosynthesis via desmosterol | R-HSA-6807047 | 4.814324e-01 | 0.317 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 4.814324e-01 | 0.317 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 4.814324e-01 | 0.317 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 4.814324e-01 | 0.317 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 4.884321e-01 | 0.311 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 4.884321e-01 | 0.311 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 4.884321e-01 | 0.311 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 4.884321e-01 | 0.311 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 4.884321e-01 | 0.311 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 4.929892e-01 | 0.307 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 4.949298e-01 | 0.305 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 4.971888e-01 | 0.303 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 4.999052e-01 | 0.301 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 5.009332e-01 | 0.300 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 5.032227e-01 | 0.298 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 5.032227e-01 | 0.298 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 5.052056e-01 | 0.297 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 5.052056e-01 | 0.297 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by WNT ligand antagonists | R-HSA-3772470 | 5.052056e-01 | 0.297 | 0 | 0 |
| Signaling by activated point mutants of FGFR1 | R-HSA-1839122 | 5.052056e-01 | 0.297 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 5.052056e-01 | 0.297 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 5.052056e-01 | 0.297 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 5.052056e-01 | 0.297 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 5.052056e-01 | 0.297 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 5.052056e-01 | 0.297 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 5.052056e-01 | 0.297 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 5.052056e-01 | 0.297 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 5.088334e-01 | 0.293 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 5.088334e-01 | 0.293 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 5.088334e-01 | 0.293 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 5.114246e-01 | 0.291 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 5.123555e-01 | 0.290 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 5.169449e-01 | 0.287 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 5.177337e-01 | 0.286 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 5.228022e-01 | 0.282 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 5.278902e-01 | 0.277 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 5.278902e-01 | 0.277 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 5.278902e-01 | 0.277 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 5.278902e-01 | 0.277 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 5.278902e-01 | 0.277 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 5.278902e-01 | 0.277 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 5.278902e-01 | 0.277 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 5.278902e-01 | 0.277 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 5.278902e-01 | 0.277 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 5.278902e-01 | 0.277 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 5.278902e-01 | 0.277 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 5.303644e-01 | 0.275 | 1 | 1 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 5.322464e-01 | 0.274 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 5.347240e-01 | 0.272 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 5.458963e-01 | 0.263 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 5.458963e-01 | 0.263 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 5.458963e-01 | 0.263 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 5.458963e-01 | 0.263 | 0 | 0 |
| FGFR2c ligand binding and activation | R-HSA-190375 | 5.495362e-01 | 0.260 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 5.495362e-01 | 0.260 | 0 | 0 |
| FGFR4 ligand binding and activation | R-HSA-190322 | 5.495362e-01 | 0.260 | 0 | 0 |
| Signaling by activated point mutants of FGFR3 | R-HSA-1839130 | 5.495362e-01 | 0.260 | 0 | 0 |
| Chylomicron remodeling | R-HSA-8963901 | 5.495362e-01 | 0.260 | 0 | 0 |
| Mtb iron assimilation by chelation | R-HSA-1222449 | 5.495362e-01 | 0.260 | 0 | 0 |
| Reversible hydration of carbon dioxide | R-HSA-1475029 | 5.495362e-01 | 0.260 | 0 | 0 |
| FGFR3 mutant receptor activation | R-HSA-2033514 | 5.495362e-01 | 0.260 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 5.495362e-01 | 0.260 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 5.495362e-01 | 0.260 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 5.547716e-01 | 0.256 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 5.551817e-01 | 0.256 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 5.560382e-01 | 0.255 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 5.595402e-01 | 0.252 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR3 | R-HSA-5654227 | 5.701909e-01 | 0.244 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 5.701909e-01 | 0.244 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 5.701909e-01 | 0.244 | 0 | 0 |
| FGFR3c ligand binding and activation | R-HSA-190372 | 5.701909e-01 | 0.244 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 5.701909e-01 | 0.244 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 5.701909e-01 | 0.244 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 5.701909e-01 | 0.244 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 5.701909e-01 | 0.244 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 5.701909e-01 | 0.244 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 5.701909e-01 | 0.244 | 0 | 0 |
| Ciprofloxacin ADME | R-HSA-9793528 | 5.701909e-01 | 0.244 | 0 | 0 |
| P2Y receptors | R-HSA-417957 | 5.701909e-01 | 0.244 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 5.723812e-01 | 0.242 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 5.728888e-01 | 0.242 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 5.728888e-01 | 0.242 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 5.728888e-01 | 0.242 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 5.733247e-01 | 0.242 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 5.823794e-01 | 0.235 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 5.823794e-01 | 0.235 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 5.825393e-01 | 0.235 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 5.898998e-01 | 0.229 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 5.898998e-01 | 0.229 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 5.898998e-01 | 0.229 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 5.898998e-01 | 0.229 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 5.898998e-01 | 0.229 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 5.898998e-01 | 0.229 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 5.898998e-01 | 0.229 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 5.898998e-01 | 0.229 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 5.898998e-01 | 0.229 | 0 | 0 |
| FGFR3 ligand binding and activation | R-HSA-190239 | 5.898998e-01 | 0.229 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 5.898998e-01 | 0.229 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 5.898998e-01 | 0.229 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 5.898998e-01 | 0.229 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 5.898998e-01 | 0.229 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 5.898998e-01 | 0.229 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 5.968830e-01 | 0.224 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 5.986948e-01 | 0.223 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 5.986948e-01 | 0.223 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 5.986948e-01 | 0.223 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 5.986948e-01 | 0.223 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 6.065498e-01 | 0.217 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 6.082271e-01 | 0.216 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 6.082271e-01 | 0.216 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 6.087061e-01 | 0.216 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 6.087061e-01 | 0.216 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 6.087061e-01 | 0.216 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 6.087061e-01 | 0.216 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 6.087061e-01 | 0.216 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 6.087061e-01 | 0.216 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 6.087061e-01 | 0.216 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 6.087061e-01 | 0.216 | 0 | 0 |
| Fructose catabolism | R-HSA-70350 | 6.087061e-01 | 0.216 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 6.087061e-01 | 0.216 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 6.087061e-01 | 0.216 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 6.087061e-01 | 0.216 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 6.109175e-01 | 0.214 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 6.109175e-01 | 0.214 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 6.111512e-01 | 0.214 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 6.111512e-01 | 0.214 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 6.181606e-01 | 0.209 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 6.181606e-01 | 0.209 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 6.181606e-01 | 0.209 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 6.181606e-01 | 0.209 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 6.181606e-01 | 0.209 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 6.181606e-01 | 0.209 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 6.181606e-01 | 0.209 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 6.206170e-01 | 0.207 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 6.216708e-01 | 0.206 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 6.233102e-01 | 0.205 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 6.233102e-01 | 0.205 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 6.261842e-01 | 0.203 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 6.266510e-01 | 0.203 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 6.266510e-01 | 0.203 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 6.266510e-01 | 0.203 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 6.266510e-01 | 0.203 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 6.266510e-01 | 0.203 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 6.266510e-01 | 0.203 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 6.266510e-01 | 0.203 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 6.266510e-01 | 0.203 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 6.266510e-01 | 0.203 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 6.266510e-01 | 0.203 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 6.266510e-01 | 0.203 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 6.266510e-01 | 0.203 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 6.295105e-01 | 0.201 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 6.351729e-01 | 0.197 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 6.378659e-01 | 0.195 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 6.437741e-01 | 0.191 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 6.437741e-01 | 0.191 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 6.437741e-01 | 0.191 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 6.437741e-01 | 0.191 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 6.437741e-01 | 0.191 | 0 | 0 |
| Choline catabolism | R-HSA-6798163 | 6.437741e-01 | 0.191 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 6.485410e-01 | 0.188 | 1 | 1 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 6.506445e-01 | 0.187 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 6.509819e-01 | 0.186 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 6.556116e-01 | 0.183 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 6.561632e-01 | 0.183 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 6.561632e-01 | 0.183 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 6.580165e-01 | 0.182 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 6.601128e-01 | 0.180 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 6.601128e-01 | 0.180 | 0 | 0 |
| Activated point mutants of FGFR2 | R-HSA-2033519 | 6.601128e-01 | 0.180 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 6.601128e-01 | 0.180 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 6.601128e-01 | 0.180 | 0 | 0 |
| Nucleotide-like (purinergic) receptors | R-HSA-418038 | 6.601128e-01 | 0.180 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 6.601128e-01 | 0.180 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 6.610464e-01 | 0.180 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 6.627322e-01 | 0.179 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 6.627322e-01 | 0.179 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 6.627322e-01 | 0.179 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 6.652273e-01 | 0.177 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 6.664991e-01 | 0.176 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 6.664991e-01 | 0.176 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 6.690019e-01 | 0.175 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 6.690019e-01 | 0.175 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 6.690019e-01 | 0.175 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 6.690019e-01 | 0.175 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 6.690019e-01 | 0.175 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 6.690019e-01 | 0.175 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 6.752034e-01 | 0.171 | 1 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 6.757030e-01 | 0.170 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 6.757030e-01 | 0.170 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 6.757030e-01 | 0.170 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 6.757030e-01 | 0.170 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 6.797000e-01 | 0.168 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 6.797000e-01 | 0.168 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 6.828302e-01 | 0.166 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 6.832347e-01 | 0.165 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 6.843045e-01 | 0.165 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 6.893446e-01 | 0.162 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 6.902475e-01 | 0.161 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR2 | R-HSA-5654221 | 6.905791e-01 | 0.161 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 6.905791e-01 | 0.161 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 6.905791e-01 | 0.161 | 0 | 0 |
| Disease | R-HSA-1643685 | 6.909458e-01 | 0.161 | 1 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 6.913695e-01 | 0.160 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 6.967086e-01 | 0.157 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 6.986796e-01 | 0.156 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 7.039468e-01 | 0.152 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 7.039468e-01 | 0.152 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 7.047736e-01 | 0.152 | 0 | 0 |
| FGFR2 ligand binding and activation | R-HSA-190241 | 7.047736e-01 | 0.152 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 7.047736e-01 | 0.152 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 7.047736e-01 | 0.152 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 7.047736e-01 | 0.152 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 7.047736e-01 | 0.152 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 7.047736e-01 | 0.152 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 7.069279e-01 | 0.151 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 7.101049e-01 | 0.149 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 7.101049e-01 | 0.149 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 7.101049e-01 | 0.149 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 7.101049e-01 | 0.149 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 7.110593e-01 | 0.148 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 7.151805e-01 | 0.146 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 7.180463e-01 | 0.144 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 7.183178e-01 | 0.144 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 7.183178e-01 | 0.144 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 7.183178e-01 | 0.144 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 7.183178e-01 | 0.144 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 7.183178e-01 | 0.144 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 7.196893e-01 | 0.143 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 7.196893e-01 | 0.143 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 7.196893e-01 | 0.143 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 7.196893e-01 | 0.143 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 7.209922e-01 | 0.142 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 7.221596e-01 | 0.141 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 7.237932e-01 | 0.140 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 7.249079e-01 | 0.140 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 7.255140e-01 | 0.139 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 7.285765e-01 | 0.138 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 7.285765e-01 | 0.138 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 7.312414e-01 | 0.136 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 7.312414e-01 | 0.136 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 7.312414e-01 | 0.136 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 7.312414e-01 | 0.136 | 0 | 0 |
| WNT ligand biogenesis and trafficking | R-HSA-3238698 | 7.312414e-01 | 0.136 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 7.312414e-01 | 0.136 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 7.312414e-01 | 0.136 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 7.312414e-01 | 0.136 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 7.312414e-01 | 0.136 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 7.312414e-01 | 0.136 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 7.312414e-01 | 0.136 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 7.316447e-01 | 0.136 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 7.382570e-01 | 0.132 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 7.389794e-01 | 0.131 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 7.389794e-01 | 0.131 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 7.435728e-01 | 0.129 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 7.435728e-01 | 0.129 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 7.463206e-01 | 0.127 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 7.463206e-01 | 0.127 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 7.468504e-01 | 0.127 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 7.488907e-01 | 0.126 | 1 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 7.496775e-01 | 0.125 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 7.496775e-01 | 0.125 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 7.534960e-01 | 0.123 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 7.553391e-01 | 0.122 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 7.553391e-01 | 0.122 | 0 | 0 |
| Assembly of active LPL and LIPC lipase complexes | R-HSA-8963889 | 7.553391e-01 | 0.122 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 7.553391e-01 | 0.122 | 0 | 0 |
| Synthesis of dolichyl-phosphate | R-HSA-446199 | 7.553391e-01 | 0.122 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 7.553391e-01 | 0.122 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 7.553887e-01 | 0.122 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 7.601152e-01 | 0.119 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 7.601152e-01 | 0.119 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 7.605073e-01 | 0.119 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 7.628819e-01 | 0.118 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 7.634745e-01 | 0.117 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 7.636771e-01 | 0.117 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 7.665662e-01 | 0.115 | 0 | 0 |
| Alpha-oxidation of phytanate | R-HSA-389599 | 7.665662e-01 | 0.115 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 7.665662e-01 | 0.115 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 7.665662e-01 | 0.115 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 7.665662e-01 | 0.115 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 7.694748e-01 | 0.114 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 7.717208e-01 | 0.113 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 7.717208e-01 | 0.113 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 7.741811e-01 | 0.111 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 7.772787e-01 | 0.109 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 7.772787e-01 | 0.109 | 0 | 0 |
| Abacavir ADME | R-HSA-2161522 | 7.772787e-01 | 0.109 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 7.795247e-01 | 0.108 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 7.811167e-01 | 0.107 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 7.846948e-01 | 0.105 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 7.867605e-01 | 0.104 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 7.875003e-01 | 0.104 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 7.875003e-01 | 0.104 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 7.875003e-01 | 0.104 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 7.875003e-01 | 0.104 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 7.875003e-01 | 0.104 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 7.944332e-01 | 0.100 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 7.946751e-01 | 0.100 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 7.972534e-01 | 0.098 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 7.972534e-01 | 0.098 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 7.976993e-01 | 0.098 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 8.015481e-01 | 0.096 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 8.015481e-01 | 0.096 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 8.015481e-01 | 0.096 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 8.015481e-01 | 0.096 | 0 | 0 |
| Thyroxine biosynthesis | R-HSA-209968 | 8.065593e-01 | 0.093 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 8.065593e-01 | 0.093 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 8.065593e-01 | 0.093 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 8.065593e-01 | 0.093 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 8.065593e-01 | 0.093 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 8.065593e-01 | 0.093 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 8.084436e-01 | 0.092 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 8.084436e-01 | 0.092 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 8.111765e-01 | 0.091 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 8.129828e-01 | 0.090 | 1 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 8.151248e-01 | 0.089 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 8.154387e-01 | 0.089 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 8.154387e-01 | 0.089 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 8.154387e-01 | 0.089 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 8.154387e-01 | 0.089 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 8.154387e-01 | 0.089 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 8.154387e-01 | 0.089 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 8.154387e-01 | 0.089 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 8.162291e-01 | 0.088 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 8.187273e-01 | 0.087 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 8.212849e-01 | 0.086 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 8.215969e-01 | 0.085 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 8.215969e-01 | 0.085 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 8.220343e-01 | 0.085 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 8.239110e-01 | 0.084 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 8.239110e-01 | 0.084 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 8.239110e-01 | 0.084 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 8.239110e-01 | 0.084 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 8.239110e-01 | 0.084 | 0 | 0 |
| Synthesis of glycosylphosphatidylinositol (GPI) | R-HSA-162710 | 8.239110e-01 | 0.084 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 8.239110e-01 | 0.084 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 8.239110e-01 | 0.084 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 8.278650e-01 | 0.082 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 8.283097e-01 | 0.082 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 8.339342e-01 | 0.079 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 8.339342e-01 | 0.079 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 8.339342e-01 | 0.079 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 8.371364e-01 | 0.077 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 8.376508e-01 | 0.077 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 8.397082e-01 | 0.076 | 0 | 0 |
| Defective B3GALTL causes PpS | R-HSA-5083635 | 8.397082e-01 | 0.076 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 8.397082e-01 | 0.076 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 8.398094e-01 | 0.076 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 8.398094e-01 | 0.076 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 8.398094e-01 | 0.076 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 8.425871e-01 | 0.074 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 8.470677e-01 | 0.072 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 8.470677e-01 | 0.072 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 8.470677e-01 | 0.072 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 8.470677e-01 | 0.072 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 8.513048e-01 | 0.070 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 8.518493e-01 | 0.070 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 8.540898e-01 | 0.068 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 8.540898e-01 | 0.068 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 8.540898e-01 | 0.068 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 8.540898e-01 | 0.068 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 8.540898e-01 | 0.068 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 8.540898e-01 | 0.068 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 8.540898e-01 | 0.068 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 8.541162e-01 | 0.068 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 8.566233e-01 | 0.067 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 8.607899e-01 | 0.065 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 8.607899e-01 | 0.065 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 8.607899e-01 | 0.065 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 8.607899e-01 | 0.065 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 8.607899e-01 | 0.065 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 8.607899e-01 | 0.065 | 0 | 0 |
| Synthesis of bile acids and bile salts via 24-hydroxycholesterol | R-HSA-193775 | 8.607899e-01 | 0.065 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 8.620905e-01 | 0.064 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 8.653616e-01 | 0.063 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 8.664504e-01 | 0.062 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 8.671827e-01 | 0.062 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 8.671827e-01 | 0.062 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 8.671827e-01 | 0.062 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 8.671827e-01 | 0.062 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 8.671827e-01 | 0.062 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 8.671827e-01 | 0.062 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 8.671827e-01 | 0.062 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 8.712653e-01 | 0.060 | 0 | 0 |
| O-glycosylation of TSR domain-containing proteins | R-HSA-5173214 | 8.732823e-01 | 0.059 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 8.732823e-01 | 0.059 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 8.732823e-01 | 0.059 | 0 | 0 |
| Lysine catabolism | R-HSA-71064 | 8.732823e-01 | 0.059 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 8.732823e-01 | 0.059 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 8.770966e-01 | 0.057 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 8.775900e-01 | 0.057 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 8.791021e-01 | 0.056 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 8.791021e-01 | 0.056 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 8.804193e-01 | 0.055 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 8.846550e-01 | 0.053 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 8.846550e-01 | 0.053 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 8.846550e-01 | 0.053 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 8.846550e-01 | 0.053 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 8.846550e-01 | 0.053 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 8.847674e-01 | 0.053 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 8.847674e-01 | 0.053 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 8.889687e-01 | 0.051 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 8.899531e-01 | 0.051 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 8.899531e-01 | 0.051 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 8.899531e-01 | 0.051 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 8.899531e-01 | 0.051 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 8.899531e-01 | 0.051 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 8.930276e-01 | 0.049 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 8.950082e-01 | 0.048 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 8.950082e-01 | 0.048 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 8.966532e-01 | 0.047 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 8.998314e-01 | 0.046 | 0 | 0 |
| Heme biosynthesis | R-HSA-189451 | 8.998314e-01 | 0.046 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 9.007348e-01 | 0.045 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 9.018750e-01 | 0.045 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.044333e-01 | 0.044 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 9.077583e-01 | 0.042 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.085589e-01 | 0.042 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 9.088240e-01 | 0.042 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 9.088240e-01 | 0.042 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.113296e-01 | 0.040 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.113296e-01 | 0.040 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.113296e-01 | 0.040 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.130133e-01 | 0.040 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.143967e-01 | 0.039 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 9.170103e-01 | 0.038 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 9.170103e-01 | 0.038 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.170103e-01 | 0.038 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 9.177940e-01 | 0.037 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 9.208239e-01 | 0.036 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 9.208239e-01 | 0.036 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 9.227673e-01 | 0.035 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 9.244625e-01 | 0.034 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 9.244625e-01 | 0.034 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 9.244625e-01 | 0.034 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.244625e-01 | 0.034 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 9.266652e-01 | 0.033 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 9.279341e-01 | 0.032 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 9.279341e-01 | 0.032 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.279341e-01 | 0.032 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 9.279341e-01 | 0.032 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.279341e-01 | 0.032 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 9.299512e-01 | 0.032 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.312463e-01 | 0.031 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 9.312463e-01 | 0.031 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 9.320644e-01 | 0.031 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.340678e-01 | 0.030 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 9.341199e-01 | 0.030 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 9.346274e-01 | 0.029 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 9.374216e-01 | 0.028 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.374216e-01 | 0.028 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 9.374216e-01 | 0.028 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.381624e-01 | 0.028 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 9.402983e-01 | 0.027 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 9.402983e-01 | 0.027 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 9.430429e-01 | 0.025 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 9.447594e-01 | 0.025 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 9.456615e-01 | 0.024 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 9.481599e-01 | 0.023 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 9.481599e-01 | 0.023 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.481599e-01 | 0.023 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.481599e-01 | 0.023 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.505156e-01 | 0.022 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.505435e-01 | 0.022 | 0 | 0 |
| Digestion | R-HSA-8935690 | 9.505435e-01 | 0.022 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 9.549874e-01 | 0.020 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.549874e-01 | 0.020 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.570575e-01 | 0.019 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 9.570575e-01 | 0.019 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.570575e-01 | 0.019 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.570575e-01 | 0.019 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.588702e-01 | 0.018 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.590325e-01 | 0.018 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.605766e-01 | 0.017 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 9.605766e-01 | 0.017 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 9.609168e-01 | 0.017 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.609465e-01 | 0.017 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 9.627145e-01 | 0.017 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.627145e-01 | 0.017 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 9.627145e-01 | 0.017 | 0 | 0 |
| Digestion and absorption | R-HSA-8963743 | 9.644297e-01 | 0.016 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 9.649879e-01 | 0.015 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.660660e-01 | 0.015 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.663344e-01 | 0.015 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.668497e-01 | 0.015 | 0 | 0 |
| Latent infection - Other responses of Mtb to phagocytosis | R-HSA-1222499 | 9.676272e-01 | 0.014 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.691166e-01 | 0.014 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.695014e-01 | 0.013 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.705376e-01 | 0.013 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.705376e-01 | 0.013 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.712106e-01 | 0.013 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.713726e-01 | 0.013 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.713726e-01 | 0.013 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.715686e-01 | 0.013 | 1 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.724011e-01 | 0.012 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.735821e-01 | 0.012 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.744206e-01 | 0.011 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 9.755195e-01 | 0.011 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.755978e-01 | 0.011 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 9.755978e-01 | 0.011 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.755978e-01 | 0.011 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.755978e-01 | 0.011 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.755978e-01 | 0.011 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 9.767210e-01 | 0.010 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 9.767210e-01 | 0.010 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.793380e-01 | 0.009 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.793380e-01 | 0.009 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.797899e-01 | 0.009 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.797899e-01 | 0.009 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 9.799749e-01 | 0.009 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.804753e-01 | 0.009 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.815843e-01 | 0.008 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 9.816080e-01 | 0.008 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 9.824548e-01 | 0.008 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 9.829635e-01 | 0.007 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.832626e-01 | 0.007 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 9.833934e-01 | 0.007 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.834976e-01 | 0.007 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.836401e-01 | 0.007 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.836401e-01 | 0.007 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 9.840334e-01 | 0.007 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 9.847686e-01 | 0.007 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.847686e-01 | 0.007 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.849160e-01 | 0.007 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.861393e-01 | 0.006 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.867037e-01 | 0.006 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.867777e-01 | 0.006 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 9.867777e-01 | 0.006 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 9.872499e-01 | 0.006 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.877139e-01 | 0.005 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 9.879678e-01 | 0.005 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.880692e-01 | 0.005 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.881279e-01 | 0.005 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.885938e-01 | 0.005 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.886634e-01 | 0.005 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 9.890509e-01 | 0.005 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.904957e-01 | 0.004 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.911088e-01 | 0.004 | 0 | 0 |
| Protein folding | R-HSA-391251 | 9.917501e-01 | 0.004 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 9.924883e-01 | 0.003 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 9.931692e-01 | 0.003 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.940711e-01 | 0.003 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.943445e-01 | 0.002 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.948304e-01 | 0.002 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.948304e-01 | 0.002 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.948304e-01 | 0.002 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 9.963001e-01 | 0.002 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.967911e-01 | 0.001 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.969392e-01 | 0.001 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.974663e-01 | 0.001 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.977682e-01 | 0.001 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.979155e-01 | 0.001 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.979610e-01 | 0.001 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.982641e-01 | 0.001 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.984975e-01 | 0.001 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.986593e-01 | 0.001 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 9.990160e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.992935e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.996200e-01 | 0.000 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.996614e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.997274e-01 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 9.997387e-01 | 0.000 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 9.998597e-01 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 9.998738e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999001e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999080e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999157e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.999266e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999308e-01 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.999677e-01 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 9.999742e-01 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.999850e-01 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.999869e-01 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.999925e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999926e-01 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 9.999952e-01 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| M Phase | R-HSA-68886 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 1.110223e-16 | 15.955 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 1.887379e-15 | 14.724 | 1 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 4.551914e-15 | 14.342 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 8.437695e-15 | 14.074 | 1 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 2.853273e-14 | 13.545 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 3.116840e-12 | 11.506 | 1 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 5.483169e-12 | 11.261 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 5.520140e-12 | 11.258 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 1.351153e-11 | 10.869 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 2.361122e-11 | 10.627 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 3.031675e-11 | 10.518 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 3.221678e-11 | 10.492 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 5.119660e-11 | 10.291 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 5.526579e-11 | 10.258 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 5.809353e-11 | 10.236 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 6.170642e-11 | 10.210 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 9.823042e-11 | 10.008 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 9.823042e-11 | 10.008 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 1.123736e-10 | 9.949 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 1.504633e-10 | 9.823 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 1.640845e-10 | 9.785 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 2.312323e-10 | 9.636 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 2.685396e-10 | 9.571 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 2.853399e-10 | 9.545 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 2.881141e-10 | 9.540 | 1 | 1 |
| Cellular Senescence | R-HSA-2559583 | 3.352807e-10 | 9.475 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 4.850561e-10 | 9.314 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 5.357889e-10 | 9.271 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 5.610943e-10 | 9.251 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 6.848357e-10 | 9.164 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 9.270911e-10 | 9.033 | 1 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 1.032190e-09 | 8.986 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 1.309830e-09 | 8.883 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 1.486349e-09 | 8.828 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 2.227027e-09 | 8.652 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 2.358405e-09 | 8.627 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 2.587351e-09 | 8.587 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 2.811878e-09 | 8.551 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 3.332904e-09 | 8.477 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 7.864954e-09 | 8.104 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 7.864954e-09 | 8.104 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 7.951716e-09 | 8.100 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 8.467244e-09 | 8.072 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 9.109448e-09 | 8.041 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 1.035365e-08 | 7.985 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 1.320284e-08 | 7.879 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 1.369314e-08 | 7.863 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 1.452351e-08 | 7.838 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 1.452275e-08 | 7.838 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 1.891302e-08 | 7.723 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 2.484730e-08 | 7.605 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 2.579486e-08 | 7.588 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 2.777117e-08 | 7.556 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 2.736110e-08 | 7.563 | 1 | 0 |
| Meiotic recombination | R-HSA-912446 | 2.872094e-08 | 7.542 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 2.975036e-08 | 7.527 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 3.298634e-08 | 7.482 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 3.308849e-08 | 7.480 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 3.308849e-08 | 7.480 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 4.676461e-08 | 7.330 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 4.676461e-08 | 7.330 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 4.522959e-08 | 7.345 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 6.199721e-08 | 7.208 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 6.220709e-08 | 7.206 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 6.965430e-08 | 7.157 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 7.358553e-08 | 7.133 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 9.078049e-08 | 7.042 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 1.073187e-07 | 6.969 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 1.073187e-07 | 6.969 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 1.116738e-07 | 6.952 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 1.332116e-07 | 6.875 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 1.379712e-07 | 6.860 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 1.417793e-07 | 6.848 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 1.484284e-07 | 6.828 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 1.490531e-07 | 6.827 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 1.556622e-07 | 6.808 | 1 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 1.884533e-07 | 6.725 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 2.268866e-07 | 6.644 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 2.796072e-07 | 6.553 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 2.824045e-07 | 6.549 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 3.133222e-07 | 6.504 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 3.462398e-07 | 6.461 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 3.895794e-07 | 6.409 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 4.099899e-07 | 6.387 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 4.199737e-07 | 6.377 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 4.199737e-07 | 6.377 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 4.320943e-07 | 6.364 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 4.677369e-07 | 6.330 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 4.448259e-07 | 6.352 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 4.797260e-07 | 6.319 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 5.499821e-07 | 6.260 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 6.232525e-07 | 6.205 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 6.638203e-07 | 6.178 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 6.728838e-07 | 6.172 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 8.218273e-07 | 6.085 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 8.384905e-07 | 6.077 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 8.420256e-07 | 6.075 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 8.648185e-07 | 6.063 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 9.872075e-07 | 6.006 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 1.085504e-06 | 5.964 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 1.133542e-06 | 5.946 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 1.170612e-06 | 5.932 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 1.249615e-06 | 5.903 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 1.351060e-06 | 5.869 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 1.428798e-06 | 5.845 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 1.481360e-06 | 5.829 | 0 | 0 |
| Kinesins | R-HSA-983189 | 1.492221e-06 | 5.826 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 1.632051e-06 | 5.787 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 1.864737e-06 | 5.729 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 1.936265e-06 | 5.713 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 2.081272e-06 | 5.682 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 2.166648e-06 | 5.664 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 2.606353e-06 | 5.584 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 2.757131e-06 | 5.560 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 2.914415e-06 | 5.535 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 2.916030e-06 | 5.535 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 2.938845e-06 | 5.532 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 3.781807e-06 | 5.422 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 3.677786e-06 | 5.434 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 3.853271e-06 | 5.414 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 4.008253e-06 | 5.397 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 4.193209e-06 | 5.377 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 4.514514e-06 | 5.345 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 5.743566e-06 | 5.241 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 5.832155e-06 | 5.234 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 6.082810e-06 | 5.216 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 6.225305e-06 | 5.206 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 7.576342e-06 | 5.121 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 7.892565e-06 | 5.103 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 9.160228e-06 | 5.038 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 9.160228e-06 | 5.038 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 9.254358e-06 | 5.034 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 9.254358e-06 | 5.034 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 9.450819e-06 | 5.025 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 1.046415e-05 | 4.980 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 1.620271e-05 | 4.790 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 1.646165e-05 | 4.784 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 1.798204e-05 | 4.745 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 2.023285e-05 | 4.694 | 1 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 2.037889e-05 | 4.691 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 2.099925e-05 | 4.678 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 2.184154e-05 | 4.661 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 2.198542e-05 | 4.658 | 0 | 0 |
| Depurination | R-HSA-73927 | 2.224160e-05 | 4.653 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 2.411154e-05 | 4.618 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 2.488452e-05 | 4.604 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 2.654346e-05 | 4.576 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 3.053124e-05 | 4.515 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 3.083555e-05 | 4.511 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 4.302611e-05 | 4.366 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 4.405436e-05 | 4.356 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 5.016756e-05 | 4.300 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 5.365580e-05 | 4.270 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 5.416624e-05 | 4.266 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 5.691128e-05 | 4.245 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 5.838676e-05 | 4.234 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 6.194416e-05 | 4.208 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 6.534015e-05 | 4.185 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 6.850869e-05 | 4.164 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 6.875119e-05 | 4.163 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 7.203702e-05 | 4.142 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 7.423257e-05 | 4.129 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 8.168968e-05 | 4.088 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 8.168968e-05 | 4.088 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 8.168968e-05 | 4.088 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 8.131327e-05 | 4.090 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 8.168968e-05 | 4.088 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 8.668501e-05 | 4.062 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 8.733935e-05 | 4.059 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 9.631122e-05 | 4.016 | 1 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 1.040859e-04 | 3.983 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 1.069648e-04 | 3.971 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 1.083560e-04 | 3.965 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 1.086569e-04 | 3.964 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 1.207394e-04 | 3.918 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 1.314245e-04 | 3.881 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 1.487434e-04 | 3.828 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 1.627833e-04 | 3.788 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 1.510630e-04 | 3.821 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 1.656670e-04 | 3.781 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 1.691996e-04 | 3.772 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 1.694043e-04 | 3.771 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 1.763864e-04 | 3.754 | 1 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 1.775355e-04 | 3.751 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 1.841344e-04 | 3.735 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 1.990031e-04 | 3.701 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 2.093916e-04 | 3.679 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 2.093916e-04 | 3.679 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 2.105493e-04 | 3.677 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 2.114906e-04 | 3.675 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 2.282340e-04 | 3.642 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 2.594955e-04 | 3.586 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 2.636215e-04 | 3.579 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 2.848617e-04 | 3.545 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 2.952531e-04 | 3.530 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 3.106115e-04 | 3.508 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 3.319459e-04 | 3.479 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 3.554298e-04 | 3.449 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 4.089092e-04 | 3.388 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 3.645355e-04 | 3.438 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 4.090303e-04 | 3.388 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 4.283059e-04 | 3.368 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 4.325535e-04 | 3.364 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 4.325535e-04 | 3.364 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 4.426592e-04 | 3.354 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 4.486178e-04 | 3.348 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 4.877217e-04 | 3.312 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 4.977808e-04 | 3.303 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 4.977808e-04 | 3.303 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 5.229147e-04 | 3.282 | 0 | 0 |
| Protein folding | R-HSA-391251 | 5.330221e-04 | 3.273 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 5.450497e-04 | 3.264 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 5.870792e-04 | 3.231 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 6.360449e-04 | 3.197 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 7.734828e-04 | 3.112 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 8.006176e-04 | 3.097 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 9.821903e-04 | 3.008 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 9.640844e-04 | 3.016 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 1.049684e-03 | 2.979 | 1 | 1 |
| Deubiquitination | R-HSA-5688426 | 9.812024e-04 | 3.008 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 1.064315e-03 | 2.973 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 1.055889e-03 | 2.976 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 1.073759e-03 | 2.969 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 1.026383e-03 | 2.989 | 1 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 9.932474e-04 | 3.003 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 1.095985e-03 | 2.960 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 1.176442e-03 | 2.929 | 1 | 1 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 1.235987e-03 | 2.908 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 1.235987e-03 | 2.908 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 1.235987e-03 | 2.908 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 1.286503e-03 | 2.891 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 1.347156e-03 | 2.871 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 1.409172e-03 | 2.851 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 1.418889e-03 | 2.848 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 1.476477e-03 | 2.831 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 1.485709e-03 | 2.828 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 1.488507e-03 | 2.827 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 1.508224e-03 | 2.822 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 1.512897e-03 | 2.820 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 1.555806e-03 | 2.808 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 1.675411e-03 | 2.776 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 1.737796e-03 | 2.760 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 1.835266e-03 | 2.736 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 1.842016e-03 | 2.735 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 1.842016e-03 | 2.735 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 1.842016e-03 | 2.735 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 1.842016e-03 | 2.735 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 1.842016e-03 | 2.735 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 1.885323e-03 | 2.725 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 1.945728e-03 | 2.711 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 2.310313e-03 | 2.636 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 2.310313e-03 | 2.636 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 2.241743e-03 | 2.649 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 2.051721e-03 | 2.688 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 2.299970e-03 | 2.638 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 2.322180e-03 | 2.634 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 2.344857e-03 | 2.630 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 2.419407e-03 | 2.616 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 2.480155e-03 | 2.606 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 2.693065e-03 | 2.570 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 2.722434e-03 | 2.565 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 2.793356e-03 | 2.554 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 2.875449e-03 | 2.541 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 2.887736e-03 | 2.539 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 2.917204e-03 | 2.535 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 2.959018e-03 | 2.529 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 2.972590e-03 | 2.527 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 3.280454e-03 | 2.484 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 3.427275e-03 | 2.465 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 3.476347e-03 | 2.459 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 3.476347e-03 | 2.459 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 3.476347e-03 | 2.459 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 3.476347e-03 | 2.459 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 3.476347e-03 | 2.459 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 3.503338e-03 | 2.456 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 3.538340e-03 | 2.451 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 3.662314e-03 | 2.436 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 3.696649e-03 | 2.432 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 3.713022e-03 | 2.430 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 3.740508e-03 | 2.427 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 3.987184e-03 | 2.399 | 1 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 4.156604e-03 | 2.381 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 4.156604e-03 | 2.381 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 4.581498e-03 | 2.339 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 4.930151e-03 | 2.307 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 5.126056e-03 | 2.290 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 5.126056e-03 | 2.290 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 5.130396e-03 | 2.290 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 5.130396e-03 | 2.290 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 5.922384e-03 | 2.228 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 5.922384e-03 | 2.228 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 5.298369e-03 | 2.276 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 5.974265e-03 | 2.224 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 6.156282e-03 | 2.211 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 6.185912e-03 | 2.209 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 6.241606e-03 | 2.205 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 6.435342e-03 | 2.191 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 6.507359e-03 | 2.187 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 6.614539e-03 | 2.180 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 6.938445e-03 | 2.159 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 6.964331e-03 | 2.157 | 1 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 6.985141e-03 | 2.156 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 6.985141e-03 | 2.156 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 6.985141e-03 | 2.156 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 7.024705e-03 | 2.153 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 7.137797e-03 | 2.146 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 7.382734e-03 | 2.132 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 7.689109e-03 | 2.114 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 8.133275e-03 | 2.090 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 8.262706e-03 | 2.083 | 1 | 1 |
| Nephrin family interactions | R-HSA-373753 | 8.262706e-03 | 2.083 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 8.262706e-03 | 2.083 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 8.402853e-03 | 2.076 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 8.402853e-03 | 2.076 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 8.402853e-03 | 2.076 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 8.402853e-03 | 2.076 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 8.402853e-03 | 2.076 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 8.570386e-03 | 2.067 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 8.587614e-03 | 2.066 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 8.619393e-03 | 2.065 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 8.806530e-03 | 2.055 | 1 | 1 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 8.998961e-03 | 2.046 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 9.056428e-03 | 2.043 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 9.056428e-03 | 2.043 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 9.204850e-03 | 2.036 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 9.296483e-03 | 2.032 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 9.347069e-03 | 2.029 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 9.362400e-03 | 2.029 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 9.556191e-03 | 2.020 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 9.556191e-03 | 2.020 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 9.592776e-03 | 2.018 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 9.685912e-03 | 2.014 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 9.790599e-03 | 2.009 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 9.931145e-03 | 2.003 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 1.009805e-02 | 1.996 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 1.135218e-02 | 1.945 | 1 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 1.182182e-02 | 1.927 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 1.182182e-02 | 1.927 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 1.184857e-02 | 1.926 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 1.204662e-02 | 1.919 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 1.210340e-02 | 1.917 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 1.219601e-02 | 1.914 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 1.252655e-02 | 1.902 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 1.268082e-02 | 1.897 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 1.272500e-02 | 1.895 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 1.276931e-02 | 1.894 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 1.332799e-02 | 1.875 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 1.487891e-02 | 1.827 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 1.487891e-02 | 1.827 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 1.306850e-02 | 1.884 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 1.385839e-02 | 1.858 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 1.422063e-02 | 1.847 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 1.422063e-02 | 1.847 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 1.584005e-02 | 1.800 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 1.613156e-02 | 1.792 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 1.376878e-02 | 1.861 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 1.306850e-02 | 1.884 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 1.422063e-02 | 1.847 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 1.584005e-02 | 1.800 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 1.592989e-02 | 1.798 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 1.410691e-02 | 1.851 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 1.409890e-02 | 1.851 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 1.409890e-02 | 1.851 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 1.304119e-02 | 1.885 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 1.630271e-02 | 1.788 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 1.643735e-02 | 1.784 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 1.647646e-02 | 1.783 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 1.663914e-02 | 1.779 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 1.663914e-02 | 1.779 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 1.663914e-02 | 1.779 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 1.663914e-02 | 1.779 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 1.663914e-02 | 1.779 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 1.669404e-02 | 1.777 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 1.679552e-02 | 1.775 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 1.679552e-02 | 1.775 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 1.693427e-02 | 1.771 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 1.795032e-02 | 1.746 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 1.795032e-02 | 1.746 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 1.795032e-02 | 1.746 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 1.795032e-02 | 1.746 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 1.795032e-02 | 1.746 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 1.795032e-02 | 1.746 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 1.795032e-02 | 1.746 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 1.795032e-02 | 1.746 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 1.795032e-02 | 1.746 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 1.795032e-02 | 1.746 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 1.795032e-02 | 1.746 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 1.837998e-02 | 1.736 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 1.837998e-02 | 1.736 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 1.837998e-02 | 1.736 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 1.863767e-02 | 1.730 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 1.863767e-02 | 1.730 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 1.863767e-02 | 1.730 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 1.905898e-02 | 1.720 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 1.939802e-02 | 1.712 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 2.001666e-02 | 1.699 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 2.001666e-02 | 1.699 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 2.048705e-02 | 1.689 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 2.127170e-02 | 1.672 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 2.198311e-02 | 1.658 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 2.198311e-02 | 1.658 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 2.266826e-02 | 1.645 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 2.283243e-02 | 1.641 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 2.287972e-02 | 1.641 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 2.303024e-02 | 1.638 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 2.303024e-02 | 1.638 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 2.303024e-02 | 1.638 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 2.303024e-02 | 1.638 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 2.338209e-02 | 1.631 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 2.349436e-02 | 1.629 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 2.349436e-02 | 1.629 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 2.364053e-02 | 1.626 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 2.376576e-02 | 1.624 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 2.376576e-02 | 1.624 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 3.093754e-02 | 1.510 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 3.093754e-02 | 1.510 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 3.093754e-02 | 1.510 | 0 | 0 |
| Loss of MECP2 binding ability to 5hmC-DNA | R-HSA-9022534 | 3.093754e-02 | 1.510 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 3.093754e-02 | 1.510 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 3.093754e-02 | 1.510 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 2.548073e-02 | 1.594 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 3.060523e-02 | 1.514 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 2.673053e-02 | 1.573 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 2.673053e-02 | 1.573 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 2.810398e-02 | 1.551 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 2.810398e-02 | 1.551 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 2.386277e-02 | 1.622 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 3.173686e-02 | 1.498 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 3.159140e-02 | 1.500 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 2.813233e-02 | 1.551 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 3.060523e-02 | 1.514 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 3.033433e-02 | 1.518 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 2.739297e-02 | 1.562 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 2.724468e-02 | 1.565 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 2.844913e-02 | 1.546 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 2.486617e-02 | 1.604 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 2.961891e-02 | 1.528 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 3.143027e-02 | 1.503 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 2.486617e-02 | 1.604 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 3.030578e-02 | 1.518 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 2.515189e-02 | 1.599 | 1 | 0 |
| Unwinding of DNA | R-HSA-176974 | 2.548073e-02 | 1.594 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 2.739297e-02 | 1.562 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 2.708381e-02 | 1.567 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 2.496157e-02 | 1.603 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 3.173686e-02 | 1.498 | 0 | 0 |
| Maturation of protein E | R-HSA-9694493 | 2.486617e-02 | 1.604 | 0 | 0 |
| Maturation of protein E | R-HSA-9683683 | 2.486617e-02 | 1.604 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 3.233051e-02 | 1.490 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 3.246909e-02 | 1.489 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 3.246909e-02 | 1.489 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 3.291850e-02 | 1.483 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 3.357310e-02 | 1.474 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 3.380214e-02 | 1.471 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 3.390177e-02 | 1.470 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 3.390177e-02 | 1.470 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 3.390177e-02 | 1.470 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 3.390177e-02 | 1.470 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 3.396373e-02 | 1.469 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 3.413116e-02 | 1.467 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 3.454345e-02 | 1.462 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 3.468652e-02 | 1.460 | 0 | 0 |
| S Phase | R-HSA-69242 | 3.499650e-02 | 1.456 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 3.589354e-02 | 1.445 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 3.632207e-02 | 1.440 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 3.654884e-02 | 1.437 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 3.654884e-02 | 1.437 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 3.707445e-02 | 1.431 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 3.792106e-02 | 1.421 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 3.861721e-02 | 1.413 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 3.861721e-02 | 1.413 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 3.898584e-02 | 1.409 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 3.963193e-02 | 1.402 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 3.963193e-02 | 1.402 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 4.034322e-02 | 1.394 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 4.046121e-02 | 1.393 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 4.046121e-02 | 1.393 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 4.359872e-02 | 1.361 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 4.414351e-02 | 1.355 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 4.414351e-02 | 1.355 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 4.440298e-02 | 1.353 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 4.468674e-02 | 1.350 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 4.468674e-02 | 1.350 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 4.620717e-02 | 1.335 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 4.689377e-02 | 1.329 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 4.722529e-02 | 1.326 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 4.740295e-02 | 1.324 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 4.763765e-02 | 1.322 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 4.763765e-02 | 1.322 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 4.763765e-02 | 1.322 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 4.765885e-02 | 1.322 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 4.785067e-02 | 1.320 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 4.785067e-02 | 1.320 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 4.785067e-02 | 1.320 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 4.785067e-02 | 1.320 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 4.932901e-02 | 1.307 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 4.932901e-02 | 1.307 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 4.977262e-02 | 1.303 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 4.977262e-02 | 1.303 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 4.977262e-02 | 1.303 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 4.977262e-02 | 1.303 | 0 | 0 |
| Regulation of HMOX1 expression and activity | R-HSA-9707587 | 4.977262e-02 | 1.303 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 5.019581e-02 | 1.299 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 5.036754e-02 | 1.298 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 5.062679e-02 | 1.296 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 5.070898e-02 | 1.295 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 5.104367e-02 | 1.292 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 5.125670e-02 | 1.290 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 5.174402e-02 | 1.286 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 5.174402e-02 | 1.286 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 5.394942e-02 | 1.268 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 5.598513e-02 | 1.252 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 5.598513e-02 | 1.252 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 5.598513e-02 | 1.252 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 5.633514e-02 | 1.249 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 5.633514e-02 | 1.249 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 5.633514e-02 | 1.249 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 5.633514e-02 | 1.249 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 5.771498e-02 | 1.239 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 5.771498e-02 | 1.239 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 5.781887e-02 | 1.238 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 5.781887e-02 | 1.238 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 5.833747e-02 | 1.234 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 5.833747e-02 | 1.234 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 5.833747e-02 | 1.234 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 5.970870e-02 | 1.224 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 5.970870e-02 | 1.224 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 6.094181e-02 | 1.215 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 6.096916e-02 | 1.215 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 6.114761e-02 | 1.214 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 6.140652e-02 | 1.212 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 6.143188e-02 | 1.212 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 6.143908e-02 | 1.212 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 6.143908e-02 | 1.212 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 6.143908e-02 | 1.212 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 6.267477e-02 | 1.203 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 6.279520e-02 | 1.202 | 0 | 0 |
| TWIK-releated acid-sensitive K+ channel (TASK) | R-HSA-1299316 | 6.374492e-02 | 1.196 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 7.172312e-02 | 1.144 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 7.172312e-02 | 1.144 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 6.516189e-02 | 1.186 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 6.516189e-02 | 1.186 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 6.516189e-02 | 1.186 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 8.517814e-02 | 1.070 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 8.517814e-02 | 1.070 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 7.009207e-02 | 1.154 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 7.009207e-02 | 1.154 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 7.933871e-02 | 1.101 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 7.933871e-02 | 1.101 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 6.499311e-02 | 1.187 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 6.499311e-02 | 1.187 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 7.484907e-02 | 1.126 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 8.555694e-02 | 1.068 | 1 | 1 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 8.968790e-02 | 1.047 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 7.029066e-02 | 1.153 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 7.792369e-02 | 1.108 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 7.162688e-02 | 1.145 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 7.892711e-02 | 1.103 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 7.725258e-02 | 1.112 | 1 | 1 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 8.273034e-02 | 1.082 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 9.471091e-02 | 1.024 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 8.331792e-02 | 1.079 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 7.954242e-02 | 1.099 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 8.481092e-02 | 1.072 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 6.993459e-02 | 1.155 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 7.012712e-02 | 1.154 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 7.375836e-02 | 1.132 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 7.428639e-02 | 1.129 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 7.012712e-02 | 1.154 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 6.828633e-02 | 1.166 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 8.505893e-02 | 1.070 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 9.465169e-02 | 1.024 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 9.471091e-02 | 1.024 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 9.471091e-02 | 1.024 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 7.311333e-02 | 1.136 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 7.391675e-02 | 1.131 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 8.119685e-02 | 1.090 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 6.827864e-02 | 1.166 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 6.503855e-02 | 1.187 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 9.476245e-02 | 1.023 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 9.465169e-02 | 1.024 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 6.856371e-02 | 1.164 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 7.290440e-02 | 1.137 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 6.516189e-02 | 1.186 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 6.516189e-02 | 1.186 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 8.968790e-02 | 1.047 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 7.029066e-02 | 1.153 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 8.221145e-02 | 1.085 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 8.555694e-02 | 1.068 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 6.993459e-02 | 1.155 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 8.968790e-02 | 1.047 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 7.933871e-02 | 1.101 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 6.828633e-02 | 1.166 | 0 | 0 |
| Modulation by Mtb of host immune system | R-HSA-9637628 | 6.516189e-02 | 1.186 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 9.490647e-02 | 1.023 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 9.711345e-02 | 1.013 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 9.711345e-02 | 1.013 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 9.723210e-02 | 1.012 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 9.723210e-02 | 1.012 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 9.723210e-02 | 1.012 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 9.723210e-02 | 1.012 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 9.737760e-02 | 1.012 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 9.737760e-02 | 1.012 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 9.771291e-02 | 1.010 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 9.926068e-02 | 1.003 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 1.019011e-01 | 0.992 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 1.035889e-01 | 0.985 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 1.035889e-01 | 0.985 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 1.035983e-01 | 0.985 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 1.035983e-01 | 0.985 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 1.035983e-01 | 0.985 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 1.036699e-01 | 0.984 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 1.036699e-01 | 0.984 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 1.036699e-01 | 0.984 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 1.036699e-01 | 0.984 | 0 | 0 |
| DSCAM interactions | R-HSA-376172 | 1.038885e-01 | 0.983 | 0 | 0 |
| Activation, myristolyation of BID and translocation to mitochondria | R-HSA-75108 | 1.038885e-01 | 0.983 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 1.038885e-01 | 0.983 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 1.048447e-01 | 0.979 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 1.049144e-01 | 0.979 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 1.077133e-01 | 0.968 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 1.085107e-01 | 0.965 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 1.095082e-01 | 0.961 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 1.095082e-01 | 0.961 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 1.115697e-01 | 0.952 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 1.115697e-01 | 0.952 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 1.121551e-01 | 0.950 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 1.127320e-01 | 0.948 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 1.128549e-01 | 0.947 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 1.128549e-01 | 0.947 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 1.128549e-01 | 0.947 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 1.134666e-01 | 0.945 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 1.138372e-01 | 0.944 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 1.138372e-01 | 0.944 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 1.163296e-01 | 0.934 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 1.163296e-01 | 0.934 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 1.167128e-01 | 0.933 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 1.191815e-01 | 0.924 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 1.191815e-01 | 0.924 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.203705e-01 | 0.919 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 1.206599e-01 | 0.918 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 1.212912e-01 | 0.916 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 1.236965e-01 | 0.908 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 1.244568e-01 | 0.905 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 1.258331e-01 | 0.900 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 1.258331e-01 | 0.900 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 1.258331e-01 | 0.900 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 1.260487e-01 | 0.899 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 1.260487e-01 | 0.899 | 0 | 0 |
| Deletions in the AXIN1 gene destabilize the destruction complex | R-HSA-5467345 | 1.272148e-01 | 0.895 | 0 | 0 |
| Deletions in the AMER1 gene destabilize the destruction complex | R-HSA-5467343 | 1.272148e-01 | 0.895 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 1.272148e-01 | 0.895 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 1.272148e-01 | 0.895 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 1.294952e-01 | 0.888 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 1.294952e-01 | 0.888 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 1.343563e-01 | 0.872 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 1.359725e-01 | 0.867 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 1.360070e-01 | 0.866 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 1.401484e-01 | 0.853 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 1.401484e-01 | 0.853 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 1.401484e-01 | 0.853 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 1.401484e-01 | 0.853 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 1.417656e-01 | 0.848 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 1.419578e-01 | 0.848 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 1.428819e-01 | 0.845 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 1.428819e-01 | 0.845 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 1.428819e-01 | 0.845 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 1.428819e-01 | 0.845 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 1.428819e-01 | 0.845 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 1.428819e-01 | 0.845 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 1.472373e-01 | 0.832 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 1.472373e-01 | 0.832 | 0 | 0 |
| Signaling by FGFR1 amplification mutants | R-HSA-1839120 | 1.489725e-01 | 0.827 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 1.489725e-01 | 0.827 | 0 | 0 |
| Signaling by plasma membrane FGFR1 fusions | R-HSA-8853336 | 1.489725e-01 | 0.827 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 1.489725e-01 | 0.827 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 1.489725e-01 | 0.827 | 0 | 0 |
| Adrenaline signalling through Alpha-2 adrenergic receptor | R-HSA-392023 | 1.489725e-01 | 0.827 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 1.489725e-01 | 0.827 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 1.489725e-01 | 0.827 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 1.494248e-01 | 0.826 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 1.497834e-01 | 0.825 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 1.500358e-01 | 0.824 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 1.502534e-01 | 0.823 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 1.502534e-01 | 0.823 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 1.502534e-01 | 0.823 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 1.502534e-01 | 0.823 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 1.502534e-01 | 0.823 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 1.504026e-01 | 0.823 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 1.505083e-01 | 0.822 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 1.505083e-01 | 0.822 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 1.511100e-01 | 0.821 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 1.515173e-01 | 0.820 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 1.527388e-01 | 0.816 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 1.528767e-01 | 0.816 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 1.539962e-01 | 0.812 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 1.558082e-01 | 0.807 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 1.570198e-01 | 0.804 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 1.570198e-01 | 0.804 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 1.570198e-01 | 0.804 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 1.570198e-01 | 0.804 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 1.570198e-01 | 0.804 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 1.571191e-01 | 0.804 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 1.571191e-01 | 0.804 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 1.612358e-01 | 0.793 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 1.612358e-01 | 0.793 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 1.612358e-01 | 0.793 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 1.612358e-01 | 0.793 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 1.612358e-01 | 0.793 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 1.651711e-01 | 0.782 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 1.654132e-01 | 0.781 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 1.660089e-01 | 0.780 | 0 | 0 |
| Activation, translocation and oligomerization of BAX | R-HSA-114294 | 2.382525e-01 | 0.623 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 2.382525e-01 | 0.623 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 2.382525e-01 | 0.623 | 0 | 0 |
| Defective Mismatch Repair Associated With MLH1 | R-HSA-5545483 | 2.382525e-01 | 0.623 | 0 | 0 |
| Defective SLC2A1 causes GLUT1 deficiency syndrome 1 (GLUT1DS1) | R-HSA-5619043 | 2.382525e-01 | 0.623 | 0 | 0 |
| Defective Mismatch Repair Associated With PMS2 | R-HSA-5632987 | 2.382525e-01 | 0.623 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 2.382525e-01 | 0.623 | 0 | 0 |
| TICAM1 deficiency - HSE | R-HSA-5602566 | 2.382525e-01 | 0.623 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 2.382525e-01 | 0.623 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 1.970914e-01 | 0.705 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 1.970914e-01 | 0.705 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 1.970914e-01 | 0.705 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 1.970914e-01 | 0.705 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 1.970914e-01 | 0.705 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 1.970914e-01 | 0.705 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 1.970914e-01 | 0.705 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 2.467445e-01 | 0.608 | 0 | 0 |
| IRS activation | R-HSA-74713 | 2.467445e-01 | 0.608 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 2.467445e-01 | 0.608 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 2.467445e-01 | 0.608 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 2.467445e-01 | 0.608 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 1.902765e-01 | 0.721 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 1.760614e-01 | 0.754 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 1.760614e-01 | 0.754 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 1.760614e-01 | 0.754 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 1.760614e-01 | 0.754 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 2.967632e-01 | 0.528 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 2.967632e-01 | 0.528 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 2.967632e-01 | 0.528 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 2.967632e-01 | 0.528 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 2.967632e-01 | 0.528 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 2.967632e-01 | 0.528 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 2.610147e-01 | 0.583 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 2.610147e-01 | 0.583 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 2.068226e-01 | 0.684 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 1.857289e-01 | 0.731 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 1.674767e-01 | 0.776 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 1.674767e-01 | 0.776 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 1.674767e-01 | 0.776 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 2.607224e-01 | 0.584 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 2.607224e-01 | 0.584 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 2.607224e-01 | 0.584 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 2.310423e-01 | 0.636 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 1.852424e-01 | 0.732 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 1.852424e-01 | 0.732 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 2.037436e-01 | 0.691 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 2.905559e-01 | 0.537 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 2.905559e-01 | 0.537 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 2.905559e-01 | 0.537 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 2.000823e-01 | 0.699 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 2.816023e-01 | 0.550 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 1.691961e-01 | 0.772 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 2.355205e-01 | 0.628 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 2.060873e-01 | 0.686 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 2.283905e-01 | 0.641 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 1.946608e-01 | 0.711 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 2.213982e-01 | 0.655 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 2.213982e-01 | 0.655 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 2.145965e-01 | 0.668 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 2.837209e-01 | 0.547 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 2.371398e-01 | 0.625 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 3.170354e-01 | 0.499 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 3.169978e-01 | 0.499 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 3.316717e-01 | 0.479 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 1.912403e-01 | 0.718 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 2.984784e-01 | 0.525 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 2.068226e-01 | 0.684 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 2.837209e-01 | 0.547 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 1.955152e-01 | 0.709 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 1.955152e-01 | 0.709 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 2.694199e-01 | 0.570 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 2.816023e-01 | 0.550 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 2.355205e-01 | 0.628 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 2.310423e-01 | 0.636 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 2.629763e-01 | 0.580 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 3.170354e-01 | 0.499 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 2.355205e-01 | 0.628 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 1.832328e-01 | 0.737 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 2.816023e-01 | 0.550 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 2.597014e-01 | 0.586 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 3.283666e-01 | 0.484 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 2.531332e-01 | 0.597 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 2.610147e-01 | 0.583 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 3.076459e-01 | 0.512 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 2.967632e-01 | 0.528 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 2.037436e-01 | 0.691 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 2.986648e-01 | 0.525 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 2.722394e-01 | 0.565 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 1.803283e-01 | 0.744 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 3.283666e-01 | 0.484 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 1.832328e-01 | 0.737 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 3.113391e-01 | 0.507 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 2.006146e-01 | 0.698 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 1.970914e-01 | 0.705 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 2.467445e-01 | 0.608 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 1.835060e-01 | 0.736 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 1.835060e-01 | 0.736 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 2.310423e-01 | 0.636 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 1.670294e-01 | 0.777 | 0 | 0 |
| Translation | R-HSA-72766 | 2.060587e-01 | 0.686 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 2.000823e-01 | 0.699 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 2.066705e-01 | 0.685 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 2.315375e-01 | 0.635 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 2.066705e-01 | 0.685 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 2.359871e-01 | 0.627 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 2.251001e-01 | 0.648 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 2.967632e-01 | 0.528 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 2.967632e-01 | 0.528 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 2.359871e-01 | 0.627 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 2.937554e-01 | 0.532 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 2.000823e-01 | 0.699 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 3.153646e-01 | 0.501 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 1.902765e-01 | 0.721 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 1.902765e-01 | 0.721 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 2.627917e-01 | 0.580 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 3.186790e-01 | 0.497 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 2.302607e-01 | 0.638 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 2.175290e-01 | 0.662 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 2.627917e-01 | 0.580 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 2.251001e-01 | 0.648 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 2.607224e-01 | 0.584 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 3.118106e-01 | 0.506 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 2.952984e-01 | 0.530 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 2.228595e-01 | 0.652 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 2.560181e-01 | 0.592 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 1.675703e-01 | 0.776 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 2.522909e-01 | 0.598 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 2.986648e-01 | 0.525 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 2.355205e-01 | 0.628 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 2.952785e-01 | 0.530 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 3.055716e-01 | 0.515 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 2.382525e-01 | 0.623 | 0 | 0 |
| MTF1 activates gene expression | R-HSA-5660489 | 1.970914e-01 | 0.705 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 2.467445e-01 | 0.608 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 2.251001e-01 | 0.648 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 2.967632e-01 | 0.528 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 2.068226e-01 | 0.684 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 2.000823e-01 | 0.699 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 2.371398e-01 | 0.625 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 3.186790e-01 | 0.497 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 2.282490e-01 | 0.642 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 2.977534e-01 | 0.526 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 2.037436e-01 | 0.691 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 2.722394e-01 | 0.565 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 1.769392e-01 | 0.752 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 1.769392e-01 | 0.752 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 1.955152e-01 | 0.709 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 1.902765e-01 | 0.721 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 1.835060e-01 | 0.736 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 2.063083e-01 | 0.685 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 3.105177e-01 | 0.508 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 1.760614e-01 | 0.754 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 1.760614e-01 | 0.754 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 2.032367e-01 | 0.692 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 2.812439e-01 | 0.551 | 1 | 1 |
| Signaling by NTRKs | R-HSA-166520 | 3.323176e-01 | 0.478 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 2.816023e-01 | 0.550 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 3.316717e-01 | 0.479 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 2.032367e-01 | 0.692 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 2.310423e-01 | 0.636 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 2.434782e-01 | 0.614 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 2.816023e-01 | 0.550 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 1.835060e-01 | 0.736 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 2.467445e-01 | 0.608 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 1.760614e-01 | 0.754 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 1.760614e-01 | 0.754 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 3.076487e-01 | 0.512 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 2.922058e-01 | 0.534 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 2.310423e-01 | 0.636 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 1.852424e-01 | 0.732 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 2.967632e-01 | 0.528 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 2.607224e-01 | 0.584 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 2.496634e-01 | 0.603 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 2.293332e-01 | 0.640 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 2.216033e-01 | 0.654 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 3.005299e-01 | 0.522 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 2.610147e-01 | 0.583 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 2.129463e-01 | 0.672 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 2.251001e-01 | 0.648 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 1.857289e-01 | 0.731 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 3.323495e-01 | 0.478 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 3.340147e-01 | 0.476 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 3.340147e-01 | 0.476 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 3.340147e-01 | 0.476 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 3.344041e-01 | 0.476 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 3.344041e-01 | 0.476 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 3.344041e-01 | 0.476 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 3.344041e-01 | 0.476 | 0 | 0 |
| NFG and proNGF binds to p75NTR | R-HSA-205017 | 3.351693e-01 | 0.475 | 0 | 0 |
| Mitochondrial transcription initiation | R-HSA-163282 | 3.351693e-01 | 0.475 | 0 | 0 |
| Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS) | R-HSA-5619081 | 3.351693e-01 | 0.475 | 0 | 0 |
| Loss of Function of SMAD4 in Cancer | R-HSA-3304347 | 3.351693e-01 | 0.475 | 0 | 0 |
| Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3 | R-HSA-5083628 | 3.351693e-01 | 0.475 | 0 | 0 |
| Defective MMADHC causes MMAHCD | R-HSA-3359473 | 3.351693e-01 | 0.475 | 0 | 0 |
| Defective GFPT1 causes CMSTA1 | R-HSA-4085023 | 3.351693e-01 | 0.475 | 0 | 0 |
| Defective ABCC9 causes CMD10, ATFB12 and Cantu syndrome | R-HSA-5678420 | 3.351693e-01 | 0.475 | 0 | 0 |
| SMAD2/3 MH2 Domain Mutants in Cancer | R-HSA-3315487 | 3.351693e-01 | 0.475 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 3.351693e-01 | 0.475 | 0 | 0 |
| TRAF3 deficiency - HSE | R-HSA-5602571 | 3.351693e-01 | 0.475 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 3.351693e-01 | 0.475 | 0 | 0 |
| Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS) | R-HSA-5660724 | 3.351693e-01 | 0.475 | 0 | 0 |
| SMAD4 MH2 Domain Mutants in Cancer | R-HSA-3311021 | 3.351693e-01 | 0.475 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 3.351693e-01 | 0.475 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 3.351693e-01 | 0.475 | 0 | 0 |
| Inhibition of Host mRNA Processing and RNA Silencing | R-HSA-168315 | 3.351693e-01 | 0.475 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 3.351693e-01 | 0.475 | 0 | 0 |
| Inhibition of membrane repair | R-HSA-9635644 | 3.351693e-01 | 0.475 | 0 | 0 |
| NTRK3 as a dependence receptor | R-HSA-9603505 | 3.351693e-01 | 0.475 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 3.385667e-01 | 0.470 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 3.423408e-01 | 0.466 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 3.454997e-01 | 0.462 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 3.462514e-01 | 0.461 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 3.462514e-01 | 0.461 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 3.462514e-01 | 0.461 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 3.462514e-01 | 0.461 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 3.462514e-01 | 0.461 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 3.462514e-01 | 0.461 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 3.462514e-01 | 0.461 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 3.512784e-01 | 0.454 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 3.512784e-01 | 0.454 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 3.512784e-01 | 0.454 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 3.512784e-01 | 0.454 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 3.517297e-01 | 0.454 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 3.517297e-01 | 0.454 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 3.517297e-01 | 0.454 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 3.544048e-01 | 0.451 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 3.575476e-01 | 0.447 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 3.581531e-01 | 0.446 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 3.605633e-01 | 0.443 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 3.605633e-01 | 0.443 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 3.661661e-01 | 0.436 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 3.661661e-01 | 0.436 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 3.661661e-01 | 0.436 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 3.661661e-01 | 0.436 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 3.661661e-01 | 0.436 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 3.661661e-01 | 0.436 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 3.711325e-01 | 0.430 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 3.711325e-01 | 0.430 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 3.711325e-01 | 0.430 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 3.711325e-01 | 0.430 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 3.711325e-01 | 0.430 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 3.711325e-01 | 0.430 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 3.711325e-01 | 0.430 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 3.711325e-01 | 0.430 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 3.711325e-01 | 0.430 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 3.711325e-01 | 0.430 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 3.817571e-01 | 0.418 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 3.817571e-01 | 0.418 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 3.817571e-01 | 0.418 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 3.817571e-01 | 0.418 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 3.817571e-01 | 0.418 | 0 | 0 |
| PKA activation | R-HSA-163615 | 3.817571e-01 | 0.418 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 3.817571e-01 | 0.418 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 3.817571e-01 | 0.418 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 3.817571e-01 | 0.418 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 3.866432e-01 | 0.413 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 3.871639e-01 | 0.412 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 3.888355e-01 | 0.410 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 3.900609e-01 | 0.409 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 3.900609e-01 | 0.409 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 3.915596e-01 | 0.407 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 3.922044e-01 | 0.406 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 3.922940e-01 | 0.406 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 3.945347e-01 | 0.404 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 3.945347e-01 | 0.404 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 3.945347e-01 | 0.404 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 3.945347e-01 | 0.404 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 3.945347e-01 | 0.404 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 3.945347e-01 | 0.404 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 3.945347e-01 | 0.404 | 0 | 0 |
| Ca2+ activated K+ channels | R-HSA-1296052 | 3.945347e-01 | 0.404 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 3.945347e-01 | 0.404 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 3.945347e-01 | 0.404 | 0 | 0 |
| Immune System | R-HSA-168256 | 3.980070e-01 | 0.400 | 1 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 4.074619e-01 | 0.390 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 4.074619e-01 | 0.390 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 4.074619e-01 | 0.390 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 4.074619e-01 | 0.390 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 4.074619e-01 | 0.390 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 4.074619e-01 | 0.390 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 4.099598e-01 | 0.387 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 4.120679e-01 | 0.385 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 4.120679e-01 | 0.385 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 4.125082e-01 | 0.385 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 4.134366e-01 | 0.384 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 4.134366e-01 | 0.384 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 4.136943e-01 | 0.383 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 4.136943e-01 | 0.383 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 4.136943e-01 | 0.383 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 4.136943e-01 | 0.383 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 4.136943e-01 | 0.383 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 4.145158e-01 | 0.382 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 4.145158e-01 | 0.382 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 4.191074e-01 | 0.378 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 4.197603e-01 | 0.377 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 4.197603e-01 | 0.377 | 0 | 0 |
| Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2 | R-HSA-5083629 | 4.197603e-01 | 0.377 | 0 | 0 |
| Defective AHCY causes HMAHCHD | R-HSA-5578997 | 4.197603e-01 | 0.377 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 4.197603e-01 | 0.377 | 0 | 0 |
| Potassium transport channels | R-HSA-1296067 | 4.197603e-01 | 0.377 | 0 | 0 |
| Defective DHDDS causes RP59 | R-HSA-4755609 | 4.197603e-01 | 0.377 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 4.197603e-01 | 0.377 | 0 | 0 |
| TGFBR2 Kinase Domain Mutants in Cancer | R-HSA-3645790 | 4.197603e-01 | 0.377 | 0 | 0 |
| Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1 | R-HSA-5083633 | 4.197603e-01 | 0.377 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 4.197603e-01 | 0.377 | 0 | 0 |
| Transcription from mitochondrial promoters | R-HSA-75944 | 4.197603e-01 | 0.377 | 0 | 0 |
| tRNA-derived small RNA (tsRNA or tRNA-related fragment, tRF) biogenesis | R-HSA-9708296 | 4.197603e-01 | 0.377 | 0 | 0 |
| Defective ABCC8 can cause hypo- and hyper-glycemias | R-HSA-5683177 | 4.197603e-01 | 0.377 | 0 | 0 |
| Loss of Function of TGFBR2 in Cancer | R-HSA-3642278 | 4.197603e-01 | 0.377 | 0 | 0 |
| ATF6B (ATF6-beta) activates chaperones | R-HSA-8874177 | 4.197603e-01 | 0.377 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 4.235716e-01 | 0.373 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 4.303323e-01 | 0.366 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 4.327839e-01 | 0.364 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 4.327839e-01 | 0.364 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 4.327839e-01 | 0.364 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 4.330487e-01 | 0.363 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 4.352554e-01 | 0.361 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 4.352554e-01 | 0.361 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 4.352554e-01 | 0.361 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 4.377047e-01 | 0.359 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 4.395224e-01 | 0.357 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 4.400407e-01 | 0.357 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 4.400407e-01 | 0.357 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 4.400407e-01 | 0.357 | 0 | 0 |
| RSK activation | R-HSA-444257 | 4.411189e-01 | 0.355 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 4.411189e-01 | 0.355 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 4.411189e-01 | 0.355 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 4.420478e-01 | 0.355 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 4.420478e-01 | 0.355 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 4.420478e-01 | 0.355 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 4.420478e-01 | 0.355 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 4.420478e-01 | 0.355 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 4.431327e-01 | 0.353 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 4.431327e-01 | 0.353 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 4.431327e-01 | 0.353 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 4.431327e-01 | 0.353 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 4.431327e-01 | 0.353 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 4.443836e-01 | 0.352 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 4.533198e-01 | 0.344 | 1 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 4.564519e-01 | 0.341 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 4.569530e-01 | 0.340 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 4.569530e-01 | 0.340 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 4.569530e-01 | 0.340 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 4.569530e-01 | 0.340 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 4.569530e-01 | 0.340 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 4.612895e-01 | 0.336 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 4.619639e-01 | 0.335 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 4.637154e-01 | 0.334 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 4.637154e-01 | 0.334 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 4.660990e-01 | 0.332 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 4.660990e-01 | 0.332 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 4.660990e-01 | 0.332 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 4.666056e-01 | 0.331 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 4.684773e-01 | 0.329 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 4.715522e-01 | 0.326 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 4.715522e-01 | 0.326 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 4.765270e-01 | 0.322 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 4.779282e-01 | 0.321 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 4.779282e-01 | 0.321 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 4.779282e-01 | 0.321 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 4.779282e-01 | 0.321 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 4.784701e-01 | 0.320 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 4.784701e-01 | 0.320 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 4.784701e-01 | 0.320 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 4.846159e-01 | 0.315 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 4.846159e-01 | 0.315 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 4.856010e-01 | 0.314 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 4.856548e-01 | 0.314 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 4.856548e-01 | 0.314 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 4.856548e-01 | 0.314 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 4.856548e-01 | 0.314 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 4.856548e-01 | 0.314 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 4.856548e-01 | 0.314 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 4.856548e-01 | 0.314 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 4.856548e-01 | 0.314 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 4.856548e-01 | 0.314 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 4.856548e-01 | 0.314 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 4.856548e-01 | 0.314 | 0 | 0 |
| Butyrophilin (BTN) family interactions | R-HSA-8851680 | 4.856548e-01 | 0.314 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 4.887482e-01 | 0.311 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 4.917747e-01 | 0.308 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 4.917747e-01 | 0.308 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 4.917747e-01 | 0.308 | 0 | 0 |
| The NLRP1 inflammasome | R-HSA-844455 | 4.935925e-01 | 0.307 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 4.935925e-01 | 0.307 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of other transcription factors | R-HSA-8866906 | 4.935925e-01 | 0.307 | 0 | 0 |
| Defective MMACHC causes MAHCC | R-HSA-3359474 | 4.935925e-01 | 0.307 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 4.935925e-01 | 0.307 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 4.935925e-01 | 0.307 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 4.935925e-01 | 0.307 | 0 | 0 |
| Defective ABCA1 causes TGD | R-HSA-5682113 | 4.935925e-01 | 0.307 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 4.935925e-01 | 0.307 | 0 | 0 |
| IRAK4 deficiency (TLR5) | R-HSA-5603037 | 4.935925e-01 | 0.307 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 4.935925e-01 | 0.307 | 0 | 0 |
| Activation of BMF and translocation to mitochondria | R-HSA-139910 | 4.935925e-01 | 0.307 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 4.935925e-01 | 0.307 | 0 | 0 |
| Histamine receptors | R-HSA-390650 | 4.935925e-01 | 0.307 | 0 | 0 |
| FasL/ CD95L signaling | R-HSA-75157 | 4.935925e-01 | 0.307 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 5.004547e-01 | 0.301 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 5.030219e-01 | 0.298 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 5.076165e-01 | 0.294 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 5.076165e-01 | 0.294 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 5.076165e-01 | 0.294 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 5.116714e-01 | 0.291 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 5.116714e-01 | 0.291 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 5.126158e-01 | 0.290 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 5.134705e-01 | 0.289 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 5.151275e-01 | 0.288 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 5.151275e-01 | 0.288 | 0 | 0 |
| Disease | R-HSA-1643685 | 5.158949e-01 | 0.287 | 1 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 5.165850e-01 | 0.287 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 5.169830e-01 | 0.287 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 5.169830e-01 | 0.287 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 5.169830e-01 | 0.287 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 5.169830e-01 | 0.287 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 5.169830e-01 | 0.287 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 5.238519e-01 | 0.281 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 5.279096e-01 | 0.277 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 5.279096e-01 | 0.277 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 5.279096e-01 | 0.277 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 5.279096e-01 | 0.277 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 5.279096e-01 | 0.277 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 5.279096e-01 | 0.277 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 5.279096e-01 | 0.277 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 5.279096e-01 | 0.277 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 5.279096e-01 | 0.277 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 5.279096e-01 | 0.277 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 5.279096e-01 | 0.277 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 5.279096e-01 | 0.277 | 0 | 0 |
| Tandem pore domain potassium channels | R-HSA-1296346 | 5.279096e-01 | 0.277 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 5.286466e-01 | 0.277 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 5.286466e-01 | 0.277 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 5.286466e-01 | 0.277 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 5.302298e-01 | 0.276 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 5.302445e-01 | 0.276 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 5.320320e-01 | 0.274 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 5.337870e-01 | 0.273 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 5.338639e-01 | 0.273 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 5.414059e-01 | 0.266 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 5.416492e-01 | 0.266 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 5.416492e-01 | 0.266 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 5.416492e-01 | 0.266 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 5.429215e-01 | 0.265 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 5.442218e-01 | 0.264 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 5.442218e-01 | 0.264 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 5.442218e-01 | 0.264 | 0 | 0 |
| Response to metal ions | R-HSA-5660526 | 5.442218e-01 | 0.264 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 5.511523e-01 | 0.259 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 5.512136e-01 | 0.259 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 5.524007e-01 | 0.258 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 5.524007e-01 | 0.258 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 5.560360e-01 | 0.255 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 5.560360e-01 | 0.255 | 0 | 0 |
| ATP sensitive Potassium channels | R-HSA-1296025 | 5.580337e-01 | 0.253 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 5.580337e-01 | 0.253 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 5.580337e-01 | 0.253 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 5.580337e-01 | 0.253 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 5.580337e-01 | 0.253 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 5.580337e-01 | 0.253 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 5.580337e-01 | 0.253 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 5.580337e-01 | 0.253 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 5.580337e-01 | 0.253 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 5.580337e-01 | 0.253 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 5.580337e-01 | 0.253 | 0 | 0 |
| Interleukin-38 signaling | R-HSA-9007892 | 5.580337e-01 | 0.253 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 5.590455e-01 | 0.253 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 5.657082e-01 | 0.247 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 5.659624e-01 | 0.247 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 5.677428e-01 | 0.246 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 5.677428e-01 | 0.246 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 5.677428e-01 | 0.246 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 5.677428e-01 | 0.246 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 5.754720e-01 | 0.240 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 5.754720e-01 | 0.240 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 5.754720e-01 | 0.240 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 5.815581e-01 | 0.235 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 5.817134e-01 | 0.235 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 5.825475e-01 | 0.235 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 5.825475e-01 | 0.235 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 5.825475e-01 | 0.235 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 5.825475e-01 | 0.235 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 5.891044e-01 | 0.230 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 5.891044e-01 | 0.230 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 5.906638e-01 | 0.229 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 5.937251e-01 | 0.226 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 5.952258e-01 | 0.225 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 5.952258e-01 | 0.225 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 5.960794e-01 | 0.225 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 6.009777e-01 | 0.221 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 6.009777e-01 | 0.221 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 6.009777e-01 | 0.221 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 6.012609e-01 | 0.221 | 0 | 0 |
| Signaling by activated point mutants of FGFR1 | R-HSA-1839122 | 6.050864e-01 | 0.218 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 6.050864e-01 | 0.218 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 6.050864e-01 | 0.218 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 6.050864e-01 | 0.218 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 6.053441e-01 | 0.218 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 6.081206e-01 | 0.216 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 6.117912e-01 | 0.213 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 6.117912e-01 | 0.213 | 0 | 0 |
| NFE2L2 regulating TCA cycle genes | R-HSA-9818025 | 6.142780e-01 | 0.212 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 6.142780e-01 | 0.212 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 6.142780e-01 | 0.212 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 6.142780e-01 | 0.212 | 0 | 0 |
| FGFR1c and Klotho ligand binding and activation | R-HSA-190374 | 6.142780e-01 | 0.212 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 6.142780e-01 | 0.212 | 0 | 0 |
| Defective F9 activation | R-HSA-9673221 | 6.142780e-01 | 0.212 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 6.142780e-01 | 0.212 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 6.142780e-01 | 0.212 | 0 | 0 |
| Defective SLC1A3 causes episodic ataxia 6 (EA6) | R-HSA-5619062 | 6.142780e-01 | 0.212 | 0 | 0 |
| PTK6 Down-Regulation | R-HSA-8849472 | 6.142780e-01 | 0.212 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 6.142780e-01 | 0.212 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 6.142780e-01 | 0.212 | 0 | 0 |
| Trafficking of myristoylated proteins to the cilium | R-HSA-5624138 | 6.142780e-01 | 0.212 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 6.142780e-01 | 0.212 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 6.142780e-01 | 0.212 | 0 | 0 |
| Zinc efflux and compartmentalization by the SLC30 family | R-HSA-435368 | 6.142780e-01 | 0.212 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 6.142780e-01 | 0.212 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 6.177463e-01 | 0.209 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 6.199186e-01 | 0.208 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 6.211974e-01 | 0.207 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 6.217902e-01 | 0.206 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 6.281131e-01 | 0.202 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 6.300573e-01 | 0.201 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 6.327087e-01 | 0.199 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 6.337307e-01 | 0.198 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 6.337856e-01 | 0.198 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 6.337856e-01 | 0.198 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 6.337856e-01 | 0.198 | 0 | 0 |
| Defective EXT2 causes exostoses 2 | R-HSA-3656237 | 6.399289e-01 | 0.194 | 0 | 0 |
| Defective EXT1 causes exostoses 1, TRPS2 and CHDS | R-HSA-3656253 | 6.399289e-01 | 0.194 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 6.399289e-01 | 0.194 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 6.399289e-01 | 0.194 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 6.399289e-01 | 0.194 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 6.412324e-01 | 0.193 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 6.442708e-01 | 0.191 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 6.442708e-01 | 0.191 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 6.473918e-01 | 0.189 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 6.548929e-01 | 0.184 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 6.548929e-01 | 0.184 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 6.548929e-01 | 0.184 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 6.562784e-01 | 0.183 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 6.562784e-01 | 0.183 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 6.568541e-01 | 0.183 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 6.607670e-01 | 0.180 | 0 | 0 |
| Plus-strand DNA synthesis | R-HSA-164525 | 6.633675e-01 | 0.178 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 6.633675e-01 | 0.178 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 6.633675e-01 | 0.178 | 0 | 0 |
| Cam-PDE 1 activation | R-HSA-111957 | 6.633675e-01 | 0.178 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 6.633675e-01 | 0.178 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 6.633675e-01 | 0.178 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 6.633675e-01 | 0.178 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 6.633675e-01 | 0.178 | 0 | 0 |
| Defective SLC29A3 causes histiocytosis-lymphadenopathy plus syndrome (HLAS) | R-HSA-5619063 | 6.633675e-01 | 0.178 | 0 | 0 |
| Signaling by RNF43 mutants | R-HSA-5340588 | 6.633675e-01 | 0.178 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 6.633675e-01 | 0.178 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 6.633675e-01 | 0.178 | 0 | 0 |
| Formation of the Editosome | R-HSA-75094 | 6.633675e-01 | 0.178 | 0 | 0 |
| Ceramide signalling | R-HSA-193681 | 6.633675e-01 | 0.178 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 6.633675e-01 | 0.178 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 6.633675e-01 | 0.178 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 6.633675e-01 | 0.178 | 0 | 0 |
| TRAIL signaling | R-HSA-75158 | 6.633675e-01 | 0.178 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 6.633675e-01 | 0.178 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 6.698488e-01 | 0.174 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 6.723021e-01 | 0.172 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 6.723021e-01 | 0.172 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 6.723021e-01 | 0.172 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 6.723021e-01 | 0.172 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 6.723021e-01 | 0.172 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 6.723021e-01 | 0.172 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 6.738164e-01 | 0.171 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 6.738164e-01 | 0.171 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 6.752554e-01 | 0.171 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 6.752554e-01 | 0.171 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 6.788073e-01 | 0.168 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 6.862776e-01 | 0.164 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 6.862776e-01 | 0.164 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 6.900302e-01 | 0.161 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 6.900302e-01 | 0.161 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 6.904407e-01 | 0.161 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 6.904407e-01 | 0.161 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 6.948028e-01 | 0.158 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 6.948028e-01 | 0.158 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 6.959010e-01 | 0.157 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 7.002837e-01 | 0.155 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 7.022701e-01 | 0.153 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 7.022701e-01 | 0.153 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 7.022701e-01 | 0.153 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 7.022701e-01 | 0.153 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 7.022701e-01 | 0.153 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 7.022701e-01 | 0.153 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 7.022701e-01 | 0.153 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 7.062120e-01 | 0.151 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 7.062120e-01 | 0.151 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 7.062120e-01 | 0.151 | 0 | 0 |
| Uncoating of the HIV Virion | R-HSA-162585 | 7.062120e-01 | 0.151 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 7.062120e-01 | 0.151 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 7.062120e-01 | 0.151 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 7.062120e-01 | 0.151 | 0 | 0 |
| Lactose synthesis | R-HSA-5653890 | 7.062120e-01 | 0.151 | 0 | 0 |
| Lipid particle organization | R-HSA-8964572 | 7.062120e-01 | 0.151 | 0 | 0 |
| VLDL assembly | R-HSA-8866423 | 7.062120e-01 | 0.151 | 0 | 0 |
| HDL clearance | R-HSA-8964011 | 7.062120e-01 | 0.151 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 7.062120e-01 | 0.151 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 7.066806e-01 | 0.151 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 7.081925e-01 | 0.150 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 7.103234e-01 | 0.149 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 7.103234e-01 | 0.149 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 7.143564e-01 | 0.146 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 7.182237e-01 | 0.144 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 7.201242e-01 | 0.143 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 7.258936e-01 | 0.139 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 7.258936e-01 | 0.139 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 7.299206e-01 | 0.137 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 7.299206e-01 | 0.137 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 7.299206e-01 | 0.137 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 7.299206e-01 | 0.137 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 7.299206e-01 | 0.137 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 7.299206e-01 | 0.137 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 7.299206e-01 | 0.137 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 7.305658e-01 | 0.136 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 7.314220e-01 | 0.136 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 7.329236e-01 | 0.135 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 7.329236e-01 | 0.135 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 7.329236e-01 | 0.135 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 7.329236e-01 | 0.135 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 7.344169e-01 | 0.134 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 7.400770e-01 | 0.131 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 7.418920e-01 | 0.130 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 7.418920e-01 | 0.130 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 7.436057e-01 | 0.129 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 7.436057e-01 | 0.129 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 7.436057e-01 | 0.129 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 7.436057e-01 | 0.129 | 0 | 0 |
| DAG1 core M1 glycosylations | R-HSA-8932506 | 7.436057e-01 | 0.129 | 0 | 0 |
| mRNA Editing: C to U Conversion | R-HSA-72200 | 7.436057e-01 | 0.129 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 7.436057e-01 | 0.129 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 7.436057e-01 | 0.129 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 7.436057e-01 | 0.129 | 0 | 0 |
| Opsins | R-HSA-419771 | 7.436057e-01 | 0.129 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 7.436057e-01 | 0.129 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 7.436057e-01 | 0.129 | 0 | 0 |
| LDL remodeling | R-HSA-8964041 | 7.436057e-01 | 0.129 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 7.436057e-01 | 0.129 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 7.436057e-01 | 0.129 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 7.436057e-01 | 0.129 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 7.455924e-01 | 0.127 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 7.484924e-01 | 0.126 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 7.484924e-01 | 0.126 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 7.541088e-01 | 0.123 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 7.541088e-01 | 0.123 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 7.541088e-01 | 0.123 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 7.553581e-01 | 0.122 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 7.553581e-01 | 0.122 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 7.553581e-01 | 0.122 | 0 | 0 |
| Activation of the phototransduction cascade | R-HSA-2485179 | 7.553581e-01 | 0.122 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 7.553581e-01 | 0.122 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 7.553581e-01 | 0.122 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 7.593905e-01 | 0.120 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 7.621491e-01 | 0.118 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 7.647438e-01 | 0.116 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 7.647438e-01 | 0.116 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 7.647438e-01 | 0.116 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 7.647438e-01 | 0.116 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 7.712325e-01 | 0.113 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 7.718482e-01 | 0.112 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 7.718482e-01 | 0.112 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 7.739187e-01 | 0.111 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 7.739187e-01 | 0.111 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 7.757276e-01 | 0.110 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 7.757276e-01 | 0.110 | 0 | 0 |
| Reverse Transcription of HIV RNA | R-HSA-162589 | 7.762418e-01 | 0.110 | 0 | 0 |
| Minus-strand DNA synthesis | R-HSA-164516 | 7.762418e-01 | 0.110 | 0 | 0 |
| ALKBH3 mediated reversal of alkylation damage | R-HSA-112126 | 7.762418e-01 | 0.110 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 7.762418e-01 | 0.110 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 7.762418e-01 | 0.110 | 0 | 0 |
| DAG1 core M2 glycosylations | R-HSA-8932504 | 7.762418e-01 | 0.110 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 7.762418e-01 | 0.110 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 7.762418e-01 | 0.110 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 7.762418e-01 | 0.110 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 7.762418e-01 | 0.110 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 7.762418e-01 | 0.110 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 7.762418e-01 | 0.110 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 7.762418e-01 | 0.110 | 0 | 0 |
| Fructose biosynthesis | R-HSA-5652227 | 7.762418e-01 | 0.110 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 7.762418e-01 | 0.110 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 7.762418e-01 | 0.110 | 0 | 0 |
| Neurotransmitter uptake and metabolism In glial cells | R-HSA-112313 | 7.762418e-01 | 0.110 | 0 | 0 |
| Astrocytic Glutamate-Glutamine Uptake And Metabolism | R-HSA-210455 | 7.762418e-01 | 0.110 | 0 | 0 |
| Alpha-defensins | R-HSA-1462054 | 7.762418e-01 | 0.110 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 7.762418e-01 | 0.110 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 7.762418e-01 | 0.110 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 7.767010e-01 | 0.110 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 7.786977e-01 | 0.109 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 7.786977e-01 | 0.109 | 0 | 0 |
| Defective B4GALT7 causes EDS, progeroid type | R-HSA-3560783 | 7.786977e-01 | 0.109 | 0 | 0 |
| Defective B3GALT6 causes EDSP2 and SEMDJL1 | R-HSA-4420332 | 7.786977e-01 | 0.109 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 7.801866e-01 | 0.108 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 7.858173e-01 | 0.105 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 7.873123e-01 | 0.104 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 7.920482e-01 | 0.101 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 7.923996e-01 | 0.101 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 7.923996e-01 | 0.101 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 7.923996e-01 | 0.101 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 7.923996e-01 | 0.101 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 7.923996e-01 | 0.101 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 7.923996e-01 | 0.101 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 7.948351e-01 | 0.100 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 7.948351e-01 | 0.100 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 7.966756e-01 | 0.099 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 7.966756e-01 | 0.099 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 7.966756e-01 | 0.099 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 7.969500e-01 | 0.099 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 8.000614e-01 | 0.097 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 8.000614e-01 | 0.097 | 0 | 0 |
| Defective B3GAT3 causes JDSSDHD | R-HSA-3560801 | 8.000614e-01 | 0.097 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 8.000614e-01 | 0.097 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 8.000614e-01 | 0.097 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 8.000614e-01 | 0.097 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 8.000614e-01 | 0.097 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 8.035182e-01 | 0.095 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 8.035182e-01 | 0.095 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 8.041622e-01 | 0.095 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 8.047253e-01 | 0.094 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 8.047253e-01 | 0.094 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 8.047253e-01 | 0.094 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 8.047253e-01 | 0.094 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 8.047253e-01 | 0.094 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 8.047253e-01 | 0.094 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 8.047253e-01 | 0.094 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 8.047253e-01 | 0.094 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 8.047253e-01 | 0.094 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 8.047253e-01 | 0.094 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 8.047253e-01 | 0.094 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 8.047253e-01 | 0.094 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 8.047253e-01 | 0.094 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 8.047253e-01 | 0.094 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 8.074009e-01 | 0.093 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 8.074009e-01 | 0.093 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 8.096036e-01 | 0.092 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 8.096036e-01 | 0.092 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 8.117098e-01 | 0.091 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 8.117858e-01 | 0.091 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 8.169552e-01 | 0.088 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 8.195740e-01 | 0.086 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 8.195740e-01 | 0.086 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 8.195740e-01 | 0.086 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 8.195740e-01 | 0.086 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 8.218167e-01 | 0.085 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 8.218200e-01 | 0.085 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 8.255865e-01 | 0.083 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 8.255865e-01 | 0.083 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 8.255865e-01 | 0.083 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 8.255865e-01 | 0.083 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 8.295844e-01 | 0.081 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 8.295844e-01 | 0.081 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 8.295844e-01 | 0.081 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 8.295844e-01 | 0.081 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 8.295844e-01 | 0.081 | 0 | 0 |
| Sperm Motility And Taxes | R-HSA-1300642 | 8.295844e-01 | 0.081 | 0 | 0 |
| Defective factor IX causes hemophilia B | R-HSA-9668250 | 8.295844e-01 | 0.081 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 8.306483e-01 | 0.081 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 8.341980e-01 | 0.079 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 8.341980e-01 | 0.079 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 8.347421e-01 | 0.078 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 8.352174e-01 | 0.078 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 8.353289e-01 | 0.078 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 8.373603e-01 | 0.077 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 8.373603e-01 | 0.077 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 8.373603e-01 | 0.077 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 8.374815e-01 | 0.077 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 8.400678e-01 | 0.076 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 8.404067e-01 | 0.076 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 8.458638e-01 | 0.073 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 8.465945e-01 | 0.072 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 8.505399e-01 | 0.070 | 0 | 0 |
| DAG1 core M3 glycosylations | R-HSA-8932505 | 8.512802e-01 | 0.070 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 8.512802e-01 | 0.070 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 8.512802e-01 | 0.070 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 8.512802e-01 | 0.070 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 8.512802e-01 | 0.070 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 8.512802e-01 | 0.070 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 8.512802e-01 | 0.070 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 8.512802e-01 | 0.070 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 8.512802e-01 | 0.070 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 8.512802e-01 | 0.070 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 8.512802e-01 | 0.070 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 8.530968e-01 | 0.069 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 8.535436e-01 | 0.069 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 8.535436e-01 | 0.069 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 8.535436e-01 | 0.069 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 8.535436e-01 | 0.069 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 8.597863e-01 | 0.066 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 8.627988e-01 | 0.064 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 8.682438e-01 | 0.061 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 8.682438e-01 | 0.061 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 8.682438e-01 | 0.061 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 8.702149e-01 | 0.060 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 8.702149e-01 | 0.060 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 8.702149e-01 | 0.060 | 0 | 0 |
| Plasmalogen biosynthesis | R-HSA-75896 | 8.702149e-01 | 0.060 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 8.702149e-01 | 0.060 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 8.702149e-01 | 0.060 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 8.702149e-01 | 0.060 | 0 | 0 |
| Proton-coupled monocarboxylate transport | R-HSA-433692 | 8.702149e-01 | 0.060 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 8.708062e-01 | 0.060 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 8.810710e-01 | 0.055 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 8.810710e-01 | 0.055 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 8.815760e-01 | 0.055 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 8.815760e-01 | 0.055 | 0 | 0 |
| Metabolism of Angiotensinogen to Angiotensins | R-HSA-2022377 | 8.815760e-01 | 0.055 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 8.815760e-01 | 0.055 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 8.828109e-01 | 0.054 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 8.854767e-01 | 0.053 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 8.867399e-01 | 0.052 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 8.867399e-01 | 0.052 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 8.867399e-01 | 0.052 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 8.867399e-01 | 0.052 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 8.867399e-01 | 0.052 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 8.867399e-01 | 0.052 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 8.867399e-01 | 0.052 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 8.867399e-01 | 0.052 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 8.867399e-01 | 0.052 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 8.867399e-01 | 0.052 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 8.867399e-01 | 0.052 | 0 | 0 |
| Metallothioneins bind metals | R-HSA-5661231 | 8.867399e-01 | 0.052 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 8.893190e-01 | 0.051 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 8.904812e-01 | 0.050 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 8.906193e-01 | 0.050 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 8.909270e-01 | 0.050 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 8.916758e-01 | 0.050 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 8.936503e-01 | 0.049 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 8.944131e-01 | 0.048 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 8.944131e-01 | 0.048 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 8.992749e-01 | 0.046 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 8.994891e-01 | 0.046 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 9.011616e-01 | 0.045 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 9.011616e-01 | 0.045 | 0 | 0 |
| Reversible hydration of carbon dioxide | R-HSA-1475029 | 9.011616e-01 | 0.045 | 0 | 0 |
| rRNA modification in the mitochondrion | R-HSA-6793080 | 9.011616e-01 | 0.045 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 9.011616e-01 | 0.045 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.037144e-01 | 0.044 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 9.045707e-01 | 0.044 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 9.045707e-01 | 0.044 | 0 | 0 |
| Synthesis of UDP-N-acetyl-glucosamine | R-HSA-446210 | 9.045707e-01 | 0.044 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.077181e-01 | 0.042 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 9.082756e-01 | 0.042 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 9.082756e-01 | 0.042 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 9.097730e-01 | 0.041 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.115057e-01 | 0.040 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 9.137477e-01 | 0.039 | 0 | 0 |
| Synthesis of IPs in the nucleus | R-HSA-1855191 | 9.137477e-01 | 0.039 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 9.137477e-01 | 0.039 | 0 | 0 |
| Biosynthesis of protectins | R-HSA-9018681 | 9.137477e-01 | 0.039 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 9.137477e-01 | 0.039 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 9.137477e-01 | 0.039 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 9.137477e-01 | 0.039 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 9.137477e-01 | 0.039 | 0 | 0 |
| Biosynthesis of E-series 18(R)-resolvins | R-HSA-9023661 | 9.137477e-01 | 0.039 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 9.137477e-01 | 0.039 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 9.137477e-01 | 0.039 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 9.144353e-01 | 0.039 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 9.144353e-01 | 0.039 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 9.144353e-01 | 0.039 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 9.144353e-01 | 0.039 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 9.166257e-01 | 0.038 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.166257e-01 | 0.038 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.166916e-01 | 0.038 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 9.233358e-01 | 0.035 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 9.233358e-01 | 0.035 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 9.233358e-01 | 0.035 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 9.233358e-01 | 0.035 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 9.247317e-01 | 0.034 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 9.247317e-01 | 0.034 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 9.247317e-01 | 0.034 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 9.247317e-01 | 0.034 | 0 | 0 |
| Protein repair | R-HSA-5676934 | 9.247317e-01 | 0.034 | 0 | 0 |
| Dopamine clearance from the synaptic cleft | R-HSA-379401 | 9.247317e-01 | 0.034 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 9.247317e-01 | 0.034 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 9.247317e-01 | 0.034 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.312793e-01 | 0.031 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 9.313577e-01 | 0.031 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 9.313577e-01 | 0.031 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 9.313577e-01 | 0.031 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.331452e-01 | 0.030 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.331452e-01 | 0.030 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 9.343175e-01 | 0.030 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 9.343175e-01 | 0.030 | 0 | 0 |
| Entry of Influenza Virion into Host Cell via Endocytosis | R-HSA-168275 | 9.343175e-01 | 0.030 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 9.343175e-01 | 0.030 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 9.343175e-01 | 0.030 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 9.343175e-01 | 0.030 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 9.343175e-01 | 0.030 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 9.343175e-01 | 0.030 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 9.343175e-01 | 0.030 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 9.343175e-01 | 0.030 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 9.376808e-01 | 0.028 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 9.385805e-01 | 0.028 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 9.385805e-01 | 0.028 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 9.422838e-01 | 0.026 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 9.426830e-01 | 0.026 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 9.426830e-01 | 0.026 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 9.426830e-01 | 0.026 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 9.426830e-01 | 0.026 | 0 | 0 |
| Galactose catabolism | R-HSA-70370 | 9.426830e-01 | 0.026 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) | R-HSA-400511 | 9.426830e-01 | 0.026 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 9.426830e-01 | 0.026 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 9.426830e-01 | 0.026 | 0 | 0 |
| Defects of contact activation system (CAS) and kallikrein/kinin system (KKS) | R-HSA-9651496 | 9.426830e-01 | 0.026 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.443581e-01 | 0.025 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 9.447082e-01 | 0.025 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 9.450775e-01 | 0.025 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.464235e-01 | 0.024 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 9.499835e-01 | 0.022 | 0 | 0 |
| Biosynthesis of aspirin-triggered D-series resolvins | R-HSA-9020265 | 9.499835e-01 | 0.022 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 9.499835e-01 | 0.022 | 0 | 0 |
| Sulfide oxidation to sulfate | R-HSA-1614517 | 9.499835e-01 | 0.022 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 9.499835e-01 | 0.022 | 0 | 0 |
| Choline catabolism | R-HSA-6798163 | 9.499835e-01 | 0.022 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 9.509163e-01 | 0.022 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 9.509163e-01 | 0.022 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.532023e-01 | 0.021 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.532961e-01 | 0.021 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 9.537207e-01 | 0.021 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 9.561593e-01 | 0.019 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.561593e-01 | 0.019 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 9.561593e-01 | 0.019 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 9.563544e-01 | 0.019 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 9.563544e-01 | 0.019 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 9.563544e-01 | 0.019 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.601670e-01 | 0.018 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 9.608634e-01 | 0.017 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 9.608634e-01 | 0.017 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 9.608634e-01 | 0.017 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 9.619142e-01 | 0.017 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 9.619142e-01 | 0.017 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 9.619142e-01 | 0.017 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 9.619142e-01 | 0.017 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 9.621730e-01 | 0.017 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 9.621730e-01 | 0.017 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 9.621730e-01 | 0.017 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.634000e-01 | 0.016 | 0 | 0 |
| HS-GAG degradation | R-HSA-2024096 | 9.650807e-01 | 0.015 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 9.655433e-01 | 0.015 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.656774e-01 | 0.015 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.658328e-01 | 0.015 | 0 | 0 |
| Mitochondrial iron-sulfur cluster biogenesis | R-HSA-1362409 | 9.667660e-01 | 0.015 | 0 | 0 |
| Wax and plasmalogen biosynthesis | R-HSA-8848584 | 9.667660e-01 | 0.015 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 9.667660e-01 | 0.015 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 9.667660e-01 | 0.015 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 9.688591e-01 | 0.014 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.690158e-01 | 0.014 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 9.691566e-01 | 0.014 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 9.696576e-01 | 0.013 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 9.710000e-01 | 0.013 | 0 | 0 |
| Matriglycan biosynthesis on DAG1 | R-HSA-9939291 | 9.710000e-01 | 0.013 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 9.710000e-01 | 0.013 | 0 | 0 |
| Intrinsic Pathway of Fibrin Clot Formation | R-HSA-140837 | 9.710000e-01 | 0.013 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 9.710000e-01 | 0.013 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 9.710000e-01 | 0.013 | 0 | 0 |
| Biosynthesis of E-series 18(S)-resolvins | R-HSA-9018896 | 9.710000e-01 | 0.013 | 0 | 0 |
| Vitamin C (ascorbate) metabolism | R-HSA-196836 | 9.710000e-01 | 0.013 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 9.710000e-01 | 0.013 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.712717e-01 | 0.013 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.712848e-01 | 0.013 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.721729e-01 | 0.012 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.722707e-01 | 0.012 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 9.746948e-01 | 0.011 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 9.746948e-01 | 0.011 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 9.746948e-01 | 0.011 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 9.749081e-01 | 0.011 | 0 | 0 |
| Glycosaminoglycan-protein linkage region biosynthesis | R-HSA-1971475 | 9.752682e-01 | 0.011 | 0 | 0 |
| RA biosynthesis pathway | R-HSA-5365859 | 9.752682e-01 | 0.011 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 9.752682e-01 | 0.011 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.757598e-01 | 0.011 | 1 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.757745e-01 | 0.011 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.765048e-01 | 0.010 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 9.779191e-01 | 0.010 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 9.779191e-01 | 0.010 | 0 | 0 |
| Biosynthesis of D-series resolvins | R-HSA-9018676 | 9.779191e-01 | 0.010 | 0 | 0 |
| Cellular hexose transport | R-HSA-189200 | 9.779191e-01 | 0.010 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 9.779191e-01 | 0.010 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 9.779191e-01 | 0.010 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 9.779743e-01 | 0.010 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.798827e-01 | 0.009 | 0 | 0 |
| HS-GAG biosynthesis | R-HSA-2022928 | 9.803926e-01 | 0.009 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 9.803926e-01 | 0.009 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.806674e-01 | 0.008 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 9.807327e-01 | 0.008 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 9.807327e-01 | 0.008 | 0 | 0 |
| Mitochondrial mRNA modification | R-HSA-9937008 | 9.807327e-01 | 0.008 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.823192e-01 | 0.008 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.824197e-01 | 0.008 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.824197e-01 | 0.008 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 9.831879e-01 | 0.007 | 0 | 0 |
| Assembly of active LPL and LIPC lipase complexes | R-HSA-8963889 | 9.831879e-01 | 0.007 | 0 | 0 |
| Synthesis of dolichyl-phosphate | R-HSA-446199 | 9.831879e-01 | 0.007 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.834132e-01 | 0.007 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.834975e-01 | 0.007 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 9.840560e-01 | 0.007 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.844802e-01 | 0.007 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.852718e-01 | 0.006 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.852850e-01 | 0.006 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 9.853304e-01 | 0.006 | 0 | 0 |
| Defects in cobalamin (B12) metabolism | R-HSA-3296469 | 9.853304e-01 | 0.006 | 0 | 0 |
| Fertilization | R-HSA-1187000 | 9.853304e-01 | 0.006 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 9.855471e-01 | 0.006 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 9.871999e-01 | 0.006 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 9.871999e-01 | 0.006 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 9.871999e-01 | 0.006 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 9.871999e-01 | 0.006 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 9.880083e-01 | 0.005 | 0 | 0 |
| Cobalamin (Cbl) metabolism | R-HSA-9759218 | 9.888313e-01 | 0.005 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 9.888313e-01 | 0.005 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 9.888313e-01 | 0.005 | 0 | 0 |
| Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane | R-HSA-83936 | 9.888313e-01 | 0.005 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.900257e-01 | 0.004 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 9.902548e-01 | 0.004 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.903191e-01 | 0.004 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.903191e-01 | 0.004 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 9.903191e-01 | 0.004 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.912158e-01 | 0.004 | 0 | 0 |
| Thyroxine biosynthesis | R-HSA-209968 | 9.914970e-01 | 0.004 | 0 | 0 |
| Biosynthesis of EPA-derived SPMs | R-HSA-9018679 | 9.914970e-01 | 0.004 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.925809e-01 | 0.003 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.927602e-01 | 0.003 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.930147e-01 | 0.003 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.930943e-01 | 0.003 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.930943e-01 | 0.003 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.932284e-01 | 0.003 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.933277e-01 | 0.003 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 9.939926e-01 | 0.003 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.939926e-01 | 0.003 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.942277e-01 | 0.003 | 0 | 0 |
| DAG1 glycosylations | R-HSA-8931838 | 9.943520e-01 | 0.002 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 9.943520e-01 | 0.002 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.943901e-01 | 0.002 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.946734e-01 | 0.002 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.949747e-01 | 0.002 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.957004e-01 | 0.002 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.957004e-01 | 0.002 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.958124e-01 | 0.002 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.962487e-01 | 0.002 | 0 | 0 |
| Phosphate bond hydrolysis by NUDT proteins | R-HSA-2393930 | 9.962487e-01 | 0.002 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.966429e-01 | 0.001 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.967270e-01 | 0.001 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.967270e-01 | 0.001 | 0 | 0 |
| Metabolism of ingested SeMet, Sec, MeSec into H2Se | R-HSA-2408508 | 9.967270e-01 | 0.001 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.970877e-01 | 0.001 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.971444e-01 | 0.001 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.974154e-01 | 0.001 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.974625e-01 | 0.001 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.975086e-01 | 0.001 | 0 | 0 |
| Lysine catabolism | R-HSA-71064 | 9.975086e-01 | 0.001 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.975086e-01 | 0.001 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.976957e-01 | 0.001 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 9.981036e-01 | 0.001 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.982504e-01 | 0.001 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 9.983455e-01 | 0.001 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 9.983455e-01 | 0.001 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.983455e-01 | 0.001 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.984234e-01 | 0.001 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.985339e-01 | 0.001 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.985565e-01 | 0.001 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.986002e-01 | 0.001 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.986255e-01 | 0.001 | 0 | 0 |
| Heparan sulfate/heparin (HS-GAG) metabolism | R-HSA-1638091 | 9.989053e-01 | 0.000 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.989053e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.989099e-01 | 0.000 | 0 | 0 |
| Defensins | R-HSA-1461973 | 9.990415e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.990833e-01 | 0.000 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.991445e-01 | 0.000 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 9.991638e-01 | 0.000 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.991638e-01 | 0.000 | 0 | 0 |
| Methylation | R-HSA-156581 | 9.991638e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.992202e-01 | 0.000 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 9.992440e-01 | 0.000 | 0 | 0 |
| The canonical retinoid cycle in rods (twilight vision) | R-HSA-2453902 | 9.992705e-01 | 0.000 | 0 | 0 |
| Degradation of cysteine and homocysteine | R-HSA-1614558 | 9.992705e-01 | 0.000 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.992920e-01 | 0.000 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.992944e-01 | 0.000 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.993320e-01 | 0.000 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.994098e-01 | 0.000 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.994141e-01 | 0.000 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.994150e-01 | 0.000 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.995352e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.995656e-01 | 0.000 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 9.996314e-01 | 0.000 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.996411e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.997069e-01 | 0.000 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.997204e-01 | 0.000 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.997532e-01 | 0.000 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.997652e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.997710e-01 | 0.000 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.998306e-01 | 0.000 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.998376e-01 | 0.000 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.998505e-01 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.998598e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.998903e-01 | 0.000 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.998975e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.998975e-01 | 0.000 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.999060e-01 | 0.000 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.999103e-01 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.999313e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.999386e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.999594e-01 | 0.000 | 1 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.999639e-01 | 0.000 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.999672e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.999685e-01 | 0.000 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.999693e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid catabolism | R-HSA-9840310 | 9.999760e-01 | 0.000 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.999791e-01 | 0.000 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.999818e-01 | 0.000 | 0 | 0 |
| Transport of vitamins, nucleosides, and related molecules | R-HSA-425397 | 9.999861e-01 | 0.000 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.999930e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999945e-01 | 0.000 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.999947e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.999948e-01 | 0.000 | 1 | 0 |
| Class C/3 (Metabotropic glutamate/pheromone receptors) | R-HSA-420499 | 9.999982e-01 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.999983e-01 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.999986e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.999994e-01 | 0.000 | 0 | 0 |
| Scavenging of heme from plasma | R-HSA-2168880 | 9.999995e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.999995e-01 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 9.999996e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.999997e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.999998e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.999998e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.999998e-01 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 9.999999e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999999e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.999999e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999999e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999999e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.999999e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999999e-01 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 1.000000e+00 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 1.000000e+00 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosphingolipid metabolism | R-HSA-1660662 | 1.000000e+00 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 1.000000e+00 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 1.000000e+00 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 1.000000e+00 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 1.000000e+00 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 1.000000e+00 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 1.000000e+00 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 1.000000e+00 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |